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Key Concepts •	 Although asbestos is no longer used in many
products, it will remain a public health concern well 
into the 21st century.
•	 Intact asbestos sources in buildings release few
fibers and should be left undisturbed. Damaged or
crumbling materials should be repaired or removed 
only by certified asbestos-removal professionals.
•	 Asbestos exposure is associated with a type of
pulmonary fibrosis (asbestosis), pleural
abnormalities (localized and diffuse pleural
thickening, rounded atelectasis), mesothelioma, 
and lung cancer, and it may be associated with 
cancer at some extra-thoracic sites.
About This and
Other Case 
Studies in
Environmental 
Medicine
This educational case study document is one in a series
of self-instructional modules designed to increase the
primary care provider’s knowledge of hazardous
substances in the environment and to promote the
adoption of medical practices that aid in the evaluation
and care of potentially exposed patients. The complete
series of Case Studies in Environmental Medicine is
located on the ATSDR Web site at URL: 
http://www.atsdr.cdc.gov/csem/csem.html In addition,
the downloadable PDF version of this educational series 
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Disclaimer and
Disclosure
Disclaimer
The state of knowledge regarding the treatment of
patients potentially exposed to hazardous substances in 
the environment is constantly evolving and is often 
uncertain. In developing its educational products,
ATSDR has made a diligent effort to ensure the accuracy
and the currency of the presented information. ATSDR,
however, makes no claim that the environmental
medicine and health education resources discussed in
these products comprehensively address all possible
situations related to various substances. The products
are intended for educational use to build the knowledge
of physicians and other health professionals in assessing 
the conditions and managing the treatment of patients
potentially exposed to hazardous substances. The
products are not a substitute for a health-care provider's
professional judgment. Please interpret the
environmental medicine and the health education 
resources in light of specific information regarding the
patient and in conjunction with other medical 
authorities.
Use of trade names in ATSDR products is for
identification purposes only and does not imply
endorsement by the Agency for Toxic Substances and 
Disease Registry or the U.S. Department of Health and
Human Services.
Disclosure
In compliance with continuing education requirements,
all presenters must disclose any financial or other
associations with the manufacturers of commercial
products, suppliers of commercial services, or
commercial supporters as well as any use of unlabeled
product(s) or product(s) under investigational use. CDC,
our planners, and the presenters for this seminar do not
have financial or other associations with the
manufacturers of commercial products, suppliers of
commercial services, or commercial supporters. This 
presentation does not involve the unlabeled use of a
product or product under investigational use. There was
no commercial support for this activity.
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How to Use This Course
Introduction	 The goal of Case Studies in Environmental Medicine
(CSEM) is to increase the primary care provider’s
knowledge of hazardous substances in the environment
and to help in evaluation and treating of potentially
exposed patients. This CSEM focuses on asbestos 
toxicity.
Availability	 Two versions of the Asbestos Toxicity CSEM are
available.
• 	 The HTML version 
http://www.atsdr.cdc.gov/csem/csem.asp?csem=2 
9&po=0 provides content through the Internet 
• The downloadable PDF version 
http://www.atsdr.cdc.gov/csem/asbestos_2014/do 
cs/asbestos.pdf provides content in an electronic, 
printable format, especially for those who may lack 
adequate Internet service. 
•	   The HTML version offers interactive exercises and 
prescriptive feedback to the user. 
Instructions	 To make the most effective use of this course.
•	 Take the Initial Check to assess your current
knowledge about asbestos toxicity.
•	 Read the title, learning objectives, text, and key
points in each section.
•	 Complete the progress check exercises at the end
of each section and check your answers.
•	 Complete and submit your assessment and posttest
response online if you wish to obtain continuing
education credit. Continuing education certificates
can be printed immediately upon completion.
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Instructional 
Format
This course is designed to help you learn efficiently. 
Topics are clearly labeled so that you can skip sections
or quickly scan sections you are already familiar with. 
This labeling will also allow you to use this training
material as a handy reference. To help you identify and 
absorb important content quickly, each section is
structured as follows:
Section Element Purpose
Title Serves as a “focus question” that 
you should be able to answer
after completing the section.
Learning Objectives Describes specific content 
addressed in each section and 
focuses your attention on 
important points.
Text Provides the information you 
need to answer the focus
question(s) and achieve the
learning objectives.
Key Points Highlights important issues and
helps you review.
Progress Check
Exercises
Enables you to test yourself to
determine whether you have
mastered the learning 
objectives.
Progress Check
Answers
Provide feedback to ensure you 
understand the content and can 
locate information in the text.
Learning Upon completion of the Asbestos CSEM, you will be able
Objectives to:
Content Area Objectives
Overview • Explain what asbestos is.
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Where Is • Identify where asbestos exists in the United States.
Asbestos • Describe how asbestos is released into the air.
Found?
Exposure • Identify the most important route of exposure to
Pathways asbestos which leads to health effects.
Who Is at Risk •	 Name the populations most heavily exposed to
asbestos.
•	 Describe who is at risk of domestic exposure to
asbestos.
Standards and • Explain the Occupational Safety and Health
Regulations Administration’s permissible exposure level for 
asbestos.
•	 Explain the U.S. Environmental Protection
Agency's maximum contaminant level for asbestos 
in drinking water.
Biological Fate • Identify where asbestos fibers are most likely to be
retained in the body.
Pathogenic
Changes
• Describe the hypothesis behind the mechanisms
scientists currently believe leads asbestos to induce
pathogenic changes in the lungs.
Respiratory
Effects
• Describe the most common respiratory conditions
associated with asbestos.
Other Health 
Conditions
• Identify non-respiratory conditions that might be
associated with exposure to asbestos.
Clinical • Identify the primary focuses of the patient’s
Assessment exposure history (exposure and medical).
• Describe the most typical findings on examination
of asbestosis patients.
Clinical • Describe chest radiograph findings associated with 
Assessment- other asbestos-associated diseases.
Tests • Describe pulmonary function test findings
associated with asbestosis.
Treatment and • Identify two primary strategies for managing
Management asbestos-associated diseases.
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• Describe specific strategies for managing
asbestosis.
Patient • List four instructions for patient self care.
Education and • Identify two instructions for clinical follow-up.
Counseling
Initial Check
 
Instructions This Initial Check will help you assess your current 
knowledge and skill level about asbestos toxicity. To 
take the Initial Check, read the case below, answer the 
questions that follow, and then compare your answers 
with the answers provided. 
Case	 A 66-year-old retired male presents with dyspnea on 
exertion. He first noticed the shortness of breath several 
months ago but was not concerned because it seemed 
so minor; he attributed it to aging. During the past few
months, however, the dyspnea on exertion has gradually
worsened. The patient has no other symptoms of
respiratory or cardiac disease. His medical history is 
unremarkable except for
•	 An old back injury (compression fracture of L4)
sustained while working as an electrician at a local
shipbuilding facility and
•	 A 25 pack-year history of smoking, though the
patient quit smoking 5 years ago.
On physical examination, the patient is in no apparent 
distress. Auscultation reveals bibasilar end-inspiratory
rales. There are no signs of cyanosis, no clubbing of the
fingers, and no peripheral edema. Heart sounds are
normal, as are the results of the rest of the physical
examination.
Questions 1. What further workup is required for this patient?
2. The exposure history indicates a 15-year history of
exposure to asbestos at the shipyard, beginning 35
years ago and ending 20 years ago. The patient
does not know the exposure levels but notes that
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he used a respirator during the last 5 years at the
shipyard. In addition, when he was 21 years old, he
swept floors at a vermiculite handling facility for a
summer. He notes that the vermiculite plant was
extremely dusty, but he was told it was just 
“nuisance dust.”
Are the patient's symptoms likely to be related to
asbestos exposure? Why or why not?
3.	 On a conventional chest radiograph, the radiologist 
(a certified “B Reader”) finds small, irregular
opacities in both lung bases consistent with early-
stage asbestosis. The pulmonary function tests 
reveal a mostly restrictive pattern of deficits, with
decreased carbon monoxide diffusing capacity
(DLco). You refer the patient to a pulmonologist. 
The pulmonologist diagnoses asbestosis on the
basis of the patient's exposure history, latency of
symptoms (occurring 45 years after first exposure), 
chest radiograph findings, and pulmonary function 
results.
How will you manage the patient's condition?
4.	 Is the patient at risk for other asbestos-associated
 
diseases? Why or why not?
 
5.	 Are the patient's family members at risk for
 
asbestos-associated disease as a result of their
 
association with the patient and his work with
 
asbestos?
 
6.	 The patient has been married for 46 years and has
four children. He notes that his wife laundered all
his clothes from work, including his clothes from
the summer job at the vermiculite plant and those
from his job at the shipbuilding facility. His children
had only incidental exposure from hugging him 
after work. The patient's wife, a two-pack-a-day 
smoker, has recently lost weight and developed 
sharp pains in her lower chest.
Could the wife's recent weight loss and chest pain 
be related to her husband's occupational exposure
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to asbestos? What work-up would you suggest for
the patient's wife?
7.	 The patient asks if his children are at risk of
asbestos-associated disease. How do you answer?
Initial Check 
Answers 	 
1.	 The exertional dyspnea and bibasilar end-
inspiratory rales are suggestive of some type of
interstitial pneumonitis. Because of the patient's
history of work at a shipbuilding facility, a detailed
exposure history is warranted. You should ask the
patient about
•	 Possible exposures (especially to asbestos) at
the shipbuilding facility.
•	 Other jobs at which the patient may have
been exposed directly or indirectly to
asbestos.
•	 The source, intensity, frequency, and 
duration of any exposures.
•	 The time elapsed since first exposure.
•	 Any workplace dust measurements or
cumulative fiber exposure.
•	 Use of personal protective equipment.
•	 Other sources of exposure, including 
paraoccupational exposures to or from
members of the patient’s household.
•	 Sources of environmental exposure, such as a
residence near exposed asbestos-bearing 
rock or hobbies or recreational activities that
involve materials contaminated with asbestos
(e.g., home repairs or auto maintenance).
In addition to taking a detailed exposure history, it 
is prudent to order a chest radiograph and 
pulmonary function tests.
The information for this answer comes from the
“How Should Patients Exposed to Asbestos Be
Evaluated?” section.
2. 	 Yes, the patient's condition is likely to be related to 
asbestos exposure. Diagnoses to consider include 
• 	 Asbestosis, 
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•	 Idiopathic pulmonary fibrosis,
•	 Other pneumoconiosis,
•	 Hypersensitivity pneumonitis, and
•	 Sarcoidosis and other interstitial pulmonary
diseases.
Several aspects of the patient's case point to
asbestosis as a likely diagnosis.
•	 History of exposure to asbestos in the
shipbuilding facility and Libby vermiculite
handling plant.
•	 Onset of symptoms many years after the
exposures (consistent with a long latency
period).
•	 Insidious onset of dyspnea on exertion.
•	 Bibasilar end-inspiratory rales.
The results of the chest radiograph (which should
be read by a certified “B Reader”) and pulmonary
function tests will help with the differential
diagnosis.
The information for this answer comes from the
“How Should Patients Exposed to Asbestos Be
Evaluated?” section.
3. To manage this patient's condition, you will
•	 Advise the patient to avoid any further
exposure to asbestos, tobacco smoke, and 
other respiratory irritants as practical;
•	 Provide pneumococcal and annual influenza
vaccines;
•	 Advise the patient to contact you at any sign
of chest infection;
•	 Aggressively treat any chest infections that 
develop in the patient;
•	 Advise the patient to contact you at any sign
of other health changes, particularly changes
that might be early signs of a malignancy
(e.g., hoarseness, change in cough, coughing 
up blood, sores in the mouth, blood in stool);
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•	 Arrange for colon cancer screening in 
accordance with current guidelines;
•	 Schedule regular follow-up visits to monitor
progression of the asbestosis and possible
development of other asbestos-associated
diseases;
•	 Document any impairments related to work-
related asbestos exposure; and
•	 Notify the patient that he has an occupational
disease and arrange for appropriate follow-
up. Refer the patient to an occupational 
specialist who can explain all the treatment, 
legal (such as workman compensation) and 
employment ramifications of a work-related
pulmonary disease.
The information for this answer comes from
the “How Should Patients Exposed to Asbestos
Be Treated and Managed?” section.
4.	 Yes, the patient is at risk of other asbestos-
associated diseases. The patient's past exposures 
to asbestos were significant enough to have led to
the development of asbestosis. These exposures
can also lead to the development of other asbestos-
associated diseases such as asbestos-related
pleural abnormalities, lung carcinoma, and pleural 
or peritoneal mesothelioma. Additionally, the
patient was previously a smoker and the effects of 
smoking and asbestos exposure are synergistic with
respect to lung cancer (i.e., patients with a history
of both smoking and asbestos exposure face a risk
greater than what would be expected if the
individual effects of each of these two risk factors 
were simply summed).  
The information for this answer comes from the
“What Other Health Conditions Are Associated
with Asbestos?” section.
5.	 Possibly. While taking the patient’s exposure
history, it is important to ask about possible
paraoccupational as well as environmental
14
 
 
 
    
 
  
 
 
   
 
   
 
  
 
 
 
   
   
  
  
 
   
 
  
 
 
 
  
 
  
 
 
   
 
 
 
 
  
exposures to members of the patient’s household.
These can include inhalation of asbestos fibers from
•	 The worker's skin, hair, and clothing
(depending on PPE and post work showering 
was not used);
•	 Air and dust from nearby vermiculite- or 
asbestos-handling facilities;
•	 Air and dust from nearby mining operations
or other blasting/disruption of asbestos-
bearing rock; and
•	 Outdoor recreation in areas of exposed 
asbestos-bearing rock.
You should also ask about other possible exposure
sources such as
•	 Materials used for hobbies and recreation.
•	 Outdoor activities that could involve exposure
to exposed asbestos-bearing rock,
particularly if the patient lives near a geologic
source.
•	 Vermiculite attic insulation contaminated with
asbestos.
All of these types of exposures could place family
members and other household contacts at risk of
asbestos-associated disease.
The information for this answer comes from
section the “Who Is At Risk of Exposure to 
Asbestos?” section.
6.	 Yes, the wife's symptoms could be related to her
husband's occupational exposures to asbestos.
Given that she laundered her husband's work
clothes when he had two jobs involving asbestos,
she could have received significant
paraoccupational exposures to asbestos. To
determine whether these exposures led to an 
asbestos-associated disease, you recommend that
the patient's wife:
•	 Come in for an office visit,
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• Have a chest radiograph, and
• Undergo pulmonary function tests.
The wife's chest radiograph shows a pleural 
thickening associated with a slight pleural effusion
on the lower right lung field. You refer the wife to a
pulmonologist, who orders a computed tomography
(CT) scan and performs a pleural biopsy. The
pulmonologist diagnoses pleural mesothelioma, 
refers her to a cancer center, and provides the
family with a referral for psychosocial support.
The information for this answer comes from
section the “How Should Patients Exposed to
Asbestos Be Evaluated?” section.
7.	 You explain that the risk of asbestos-associated
diseases is generally related to dose (duration
times level of exposure, or cumulative exposure) 
such that the most heavily exposed individuals are
most likely to become diseased. The children 
received paraoccupational exposure to asbestos 
from dust and residue carried home on their
father's skin and clothing, so their risk of asbestos-
associated disease is less than his occupational risk
but more than the background risk of the general
population. You note that asbestos-associated
disease, particularly mesothelioma, can occur with
paraoccupational exposure and there is an 
extremely low risk of mesothelioma with the
background exposures to asbestos experienced by
people in the general population.
The information for this answer comes from the
“What Respiratory Conditions Are Associated
with Asbestos?” section.
What Is Asbestos
 
Learning
Objectives
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Introduction	 During much of the past century, asbestos was widely
used for industrial and construction applications. In the
1970s, following enactment of various laws that 
established Federal agencies such as the Environmental
Protection Agency (EPA) and Occupational Safety and 
Health Administration (OSHA) with missions to protect 
the environment, the general public, workers, and 
consumers, some uses of asbestos began to be banned
or otherwise regulated. This was due to growing 
scientific evidence concerning the association of 
asbestos with serious health effects. For example, in
1973 the EPA banned the use of spray-on building 
insulation and fireproofing containing more than 1
percent asbestos under authority of the Clean Air Act 
[EPA 2013] https://www.epa.gov/asbestos/asbestos­
laws-and-regulations
As a result of research showing a clear link between
asbestos exposure and various serious diseases,
increasing regulation of asbestos, and high burdens of
corporate liability due to asbestos, asbestos mining in 
the United States ceased in 2002 and the commercial
use of imported asbestos in the United States has
declined dramatically since the late 1970s. However,
asbestos is still in use in some products today and 
asbestos remains in many older buildings [NIOSH
2011a].
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Definition	 Asbestos is the generic name given to a commercially
and legally defined group of six naturally occurring 
fibrous silicate minerals that have been widely used in 
commercial products. Asbestos is composed of silicate
chains bonded with magnesium, iron, calcium,
aluminum, and sodium or trace elements to form long,
thin, separable fibrils. These fibrils are arranged in 
parallel and a single microscopically-observed asbestos 
fiber can represent multiple fibrils that have not
separated.
Currently, there are varying regulatory and scientific
definitions applied to “asbestiform” and
“nonasbestiform” minerals that give origin to elongated 
particles of known or potential health concern. Many of 
these minerals are not included in the legal definition of
asbestos and are not regulated. There exists a need for 
research to identify the specific characteristics of
elongated mineral particles that determine their relative
toxicities so that exposures can be appropriately
managed to prevent associated health effects [NIOSH 
2011a].
Asbestos occurs naturally, but much of its current
presence in the environment stems from mining and 
commercial uses.
Classes Asbestos fibers are classified by mineral structure as 
serpentine or amphibole.
Table 1. Types of Asbestos
Serpentine Amphibole
18
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
Figure 1. Photo of
serpentine asbestos
Long, flexible fibers
Member: chrysotile
Currently accounts for Currently, accounts 
99% of world's for 1% of commercial,
commercial, purposeful use of
purposeful use of asbestos [NIOSH 
asbestos [NIOSH 2011a]
2011a]
Figure 2. Photo of
amphibole asbestos
Brittle with a rod or
needle shape
Members: crocidolite, 
amosite, 
anthophyllite, 
tremolite, actinolite
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Properties Asbestos was widely used commercially because of its 
• High tensile strength 
• Resistance to acids and alkalis 
• 	 Resistance to heat and flame 
• 	 Flexibility. 
These properties make asbestos commercially useful but 
also stable in the environment. Once released to the 
environment, asbestos tends to persist. 
Key Points • Asbestos is a group of fibrous silicate minerals. 
• 	 There are two classes of asbestos: serpentine and 
amphibole. 
• 	 Asbestos is now used much less widely in the 
United States and many other countries than in the 
past. 
• 	 Asbestos is stable and persists in the environment. 
Progress 1. Asbestos is a 
Check 
A. Group of fibrous mineral silicates. 
B. Naturally occurring substance. 
C. Commercially used substance. 
D. All of the above. 
To review relevant content, see “Definition” in this 
section. 
Where Is Asbestos Found?
  
Learning Upon completion of this section, you will be able to 
Objectives 
• 	 Identify where asbestos exists in the United States 
and 
• 	 Describe how asbestos is released into the air. 
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Introduction	 Asbestos was widely used in the United States until 
health concerns led to some uses being banned and 
some voluntary phase outs [Seidman and Selikoff
1990]. Since the early 1970s, use of asbestos has 
declined substantially; mining of asbestos ceased in the
United States in 2002, though some asbestos continues
to be imported [NIOSH 2011a]. 
Asbestos is still used in some construction materials. 
Some previously marketed asbestos-containing
products, such as amphibole-contaminated vermiculite
insulation, remain in many homes and other buildings in 
the United States. Asbestos fibers are released into the
air when friable asbestos-containing materials are
disturbed. In addition to being at risk for potential
exposure from degradation of asbestos-containing
commercial products, people in some areas of the world
may be at risk because of geological deposits of
asbestos at or near the earth’s surface, which can 
release asbestos by natural weathering or man-made
disturbance. Such deposits are often referred to as
“naturally occurring asbestos.”
For more information on the subject of naturally
occurring asbestos and maps showing the locations of
naturally occurring asbestos:
ATSDR website –
https://www.atsdr.cdc.gov/PHS/PHS.asp?id=28&tid=4
United States Geological Services website –
https://www2.usgs.gov/envirohealth/geohealth/images/ 
GreaterThanBenchmarksMap.png
Current
Commercial
Uses
Today, asbestos used in the United States is imported.
Recent uses of asbestos in the Unites States include
• Automobile clutches, 
• Brake pads, 
• Corrugated sheeting,  
• Imported cement pipe,  
• Roofing materials, and 
• Vinyl tile [American Thoracic Society 2004]. 
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Former Until the 1970s, asbestos was widely used in the 
Commercial construction, shipbuilding, and automotive industries, 
Uses among others. For example, asbestos was formerly used 
in some of the following items: 
• Boilers and heating vessels, 
• Cement pipe, 
• Clutch, brake, and transmission components, 
• Conduits for electrical wire, 
• Corrosive chemical containers, 
• Electric motor components, 
• Heat-protective pads, 
• Laboratory furniture, 
• Paper products, 
• Pipe covering, 
• Roofing products, 
• Sealants and coatings, 
• Insulation products, and 
• Textiles (including curtains). 
These materials remain in many buildings, ships, and 
automobiles built before 1975 [Seidman and Selikoff 
1990]. 
Contaminated Asbestos has been a contaminant in other products such 
Commercial as 
Products 
• Vermiculite in potting soil and 
• Vermiculite home insulation. 
Vermiculite contaminated with asbestos was produced 
as late as 1990 from a mine near Libby, Montana. The 
mined vermiculite ore contained amphibole asbestos. It 
was processed at 245 sites around the country, and 
contaminated vermiculite products were distributed
nationally [ATSDR 2001a]. See below for a map with a 
sample of 30 out of the 245 sites where Libby
vermiculite was processed nationwide.
Although all vermiculite currently used in potting soil is
essentially amphibole-free, pre-1990 products from the
Libby mine contain amphibole asbestos. Many homes
still have this vermiculite insulation in their attics.
22
 
 
 
  
  
   
 
   
 
  
 
 
 
 
 
For more information on amphibole asbestos and 
vermiculite insulation, please refer to the ATSDR website
on asbestos at
https://www.atsdr.cdc.gov/PHS/PHS.asp?id=28&tid=4
Figure 3.  Map of 28 ATSDR priority sites out of 245 
Libby vermiculite mining and processing sites
28 ATSDR priority sites
• Beltsville, MD • Libby, MT  • Portland, OR 
• Dallas, TX  • Los Angeles, (N. Harding)  
• Dearborn, MI  CA  • Portland, OR 
• Denver, CO  • Marysville, (N. Suttle)  
• Easthampton OH • Santa Ana, 
, MA  • Minneapolis, CA   
• Edgewater, MN  • Spokane, WA  
NJ  • Minot, ND  • St. Louis, MO  
• Ellwood City, • New Castle, • Tampa, FL  
PA  PA  • Trenton, NJ  
• Glendale, AZ  • New Orleans, • Weedsport, 
• Hamilton LA  NY  
Township, NJ  • Newark, CA  • West Chicago, 
• Honolulu, HI  • Omaha, NE  IL  
• Phoenix, AZ   • Wilder, KY 
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Homes and Besides homes that contain vermiculite insulation, 
Buildings asbestos in friable (easily pulverized or crumbled) 
construction materials is also a concern. Asbestos 
embedded in solid materials (such as wallboards) is less 
easily disturbed and therefore less likely to be released 
into the air unless it is cut, drilled, or sanded. 
Many construction materials produced before 1975 
contained asbestos including (but not limited to) 
•	  Caulking and joint compound,  
•	  Ceiling and floor tiles, 
•	  Heat resistant fabrics, and 
•	  Insulation used to cover furnaces and hot water 
and steam pipes, 
•	  Roofing shingles, 
•	  Siding shingles, 
•	  Textured paints and patching compounds used on 
wall and ceilings, 
•	  Walls and floors used with wood burning stoves 
[EPA 2012a]. 
These sources of asbestos can be disturbed during home 
redecoration, renovation, and demolition. Asbestos can 
also be released during destruction of housing stock 
during natural or technological (human-made) disasters. 
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The Natural 
Environment
As a result of human use, asbestos fibers are now
widely dispersed in the environment. Background levels
in the air are extremely low, about 0.0001 fibers/cc
[Holland and Smith 2003].
Asbestos is also present in the environment naturally, 
primarily in underground rock.
•	 In most areas asbestos fibers are not released into
the air because the rock is too deep to be disturbed 
easily. 
•	 In some areas, such as parts of California, Virginia,
and New Jersey (and across the globe in Turkey
and Corsica) where asbestos-bearing rock is close
enough to the surface that construction and other
human activities can disturb it, high concentrations
of asbestos fibers can be released into the air
[ATSDR 2001a; Constantolopoulos
2008; Hasanoglu et al. 2003; Luo et al. 2003].  
There can be clusters of cases of a rare asbestos-related
cancer, mesothelioma in places where high exposures to
naturally occurring asbestos occurs. 
•	 A recent ecological study found an elevated risk for
mesothelioma occurrence in an area in New
Caledonia where roads are covered in local rock
that contains asbestos [Baumann et al. 2011].
•	 Another ecological study in California found a
relationship between proximity to geologic sources 
of naturally occurring asbestos and incidence of 
malignant mesothelioma [Pan X et al. 2005].
Table 2. Examples of Sources of Asbestos in the
Environment.
Source of Asbestos Location in the
Environment
Mining, milling, and
weathering of asbestos-
bearing rock
Outdoor air and settled
dust
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Release of fibers from Indoor air 
disturbed building 
materials (e.g., 
vermiculite insulation) 
Manufacture, wear, and Outdoor and indoor air 
disposal of asbestos- and settled dust 
containing products 
Release of fibers from Street dust 
brake linings or crushed 
asbestos-containing rock 
used in road construction 
Erosion of natural land Drinking water 
sources, discarded mine 
and mill tailings, asbestos 
cement pipe, 
disintegration of other 
asbestos-containing 
materials transported by 
rainwater [EPA 2012b] 
Key Points •	 Until the 1970s, asbestos was widely used in the
construction, shipbuilding, and automotive
industries.
•	 Asbestos-contaminated vermiculite products were 
produced until 1990.
•	 Some home insulation and other building materials
produced before 1990 contain asbestos.
•	 Asbestos fibers are mainly released into the air
when asbestos-containing materials are disturbed.
•	 In a few areas, asbestos-bearing rock close to the
earth's surface can be disturbed and release high 
concentrations of asbestos fibers into the air.
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Progress 
Check
2. Asbestos currently in the environment comes from
A. Current production of commercial products and 
building materials.
B. Past production of commercial products and 
building materials.
C. Natural release of asbestos fibers from
weathered rock.
D. All of the above.
To review relevant content, see “The Natural 
Environment’ in this section.
3. Asbestos fibers are released into the air mainly
when
A. Asbestos-containing materials are loose, 
crumbling, or disturbed.
B. Asbestos is fixed in solid materials such as
wallboard.
C. Asbestos-bearing rock lays unexposed deep 
underground.
D. All of the above.
To review relevant content, see “Introduction” in
this section.
How Are People Exposed to Asbestos?
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Learning
Objectives
Upon completion of this section, you will be able to
•	 Identify the most important route of exposure to
asbestos which leads to health effects.
 
 
 
  
  
 
 
  
  
 
  
   
  
 
 
  
  
 
   
  
 
  
 
 
  
 
 
    
  
   
  
  
 
 
   
Introduction	 Exposure to asbestos can occur when asbestos-
containing material (man-made or natural) is disturbed 
releasing asbestos fibers into the air. Asbestos that is
embedded or contained in undisturbed solid materials
presents a negligible risk of exposure.
The primary route of asbestos entry into the body is
inhalation of air that contains asbestos fibers. Asbestos
can also enter the body via ingestion. With dermal 
exposure, asbestos fibers may lodge in the skin.
Inhalation	 The air pathway is the most important route of exposure
to asbestos. It is the route that most commonly leads to
illness. Exposure scenarios include inhalation of air that 
is contaminated:
•	 During work with asbestos,
•	 During work in the same space as others working 
with asbestos,
•	 From a worker's skin, hair, and clothing,
•	 In areas surrounding a mining operation,
•	 In areas of the world where natural weathering, 
landscaping, construction, or other human activity
(such as gardening and outdoor recreation) results
in disturbance of asbestos-bearing rock, and
•	 In homes and buildings where renovations or 
demolitions disturb asbestos-containing building 
materials.
The first four scenarios above were common until the
1970s, when the U.S. Environmental Protection Agency
(EPA) began to regulate the industrial uses of asbestos
and the Occupational Safety Health
Administration (OSHA) developed workplace exposure
standards [Seidman and Selikoff 1990]. Today, the last 
two scenarios are the more common because of
declining use of asbestos in developed countries [British
Thoracic Society 2001; NIOSH 2011a].
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Ingestion	 Ingestion—a less important pathway of exposure— 
occurs through
•	 Swallowing material removed from the lungs via
mucociliary clearance in persons who have inhaled 
asbestos fibers into the lungs [NIOSH 2011b]
•	 Drinking water contaminated with asbestos (for 
example, from erosion of natural land sources,
discarded mine and mill tailings, asbestos cement
pipe, or disintegration of other asbestos-containing 
materials transported by rainwater).
•	 Eating biota, such as clams, that are contaminated 
with asbestos [ATSDR 2013].
•	 Incidental ingestion during swimming in
contaminated water [ATSDR 2009].
Asbestos levels in most water supplies are well below
the EPA maximum contaminant level (MCL), so
significant exposure by drinking water is uncommon.
Skin	 Today, with the appropriate use of personal protective
equipment by those working with asbestos, dermal 
contact is rarely a significant exposure pathway. In the
past, handling asbestos could result in significant dermal
contact and exposure. Asbestos fibers could become
lodged in the skin, producing a callus or corn, but not
more serious health effects.
Key Points •	 The air pathway (inhalation of contaminated air) is
the most important route of exposure to asbestos
and the route that most commonly leads to illness.
•	 Ingestion is a less common exposure pathway, but
exposure can occur after swallowing of material
cleared from the lungs.
•	 Significant dermal contact is unusual, but it can
lead to calluses or corns.
Progress 
Check
4. The most important route of exposure to asbestos 
is
1. Inhalation.
2. Ingestion.
3. Dermal contact.
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4.	 All are equally important.
To review relevant content, see “Inhalation” in this
section.
Who Is at Risk of Exposure to Asbestos?
 
Learning Upon completion of this section, you will be able to
Objectives
•	 Name the populations most heavily exposed to
asbestos and
•	 Describe who is at risk of domestic exposure to
asbestos.
Introduction	 In the past, asbestos exposure was associated mainly
with mining and milling of the raw material and with
workers engaged in construction and product
manufacture or use of end products. In the industrialized 
west, these heavy asbestos exposures peaked during 
the 1960s and 1970s and then declined as worker 
protection regulations were put in place and later as
industrial use of asbestos decreased [NIOSH 2011a].
Because of long latency periods (10–40 years), workers
exposed to asbestos in the 1960s and 1970s are now
manifesting asbestos-associated diseases. Indeed, the
mortality of asbestosis has increased from the 1960s to
2000. The National Institute of Occupational Safety and
Health (NIOSH) data indicates that asbestosis deaths 
increased substantially from the 1960s to the 2000s;
they are expected to continue occurring for decades
[NIOSH 2011a; CDC 2004; Antao et al. 2009].
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National statistics that illustrate this trend are available
at
http://www2a.cdc.gov/drds/WorldReportData/FigureTabl 
eDetails.asp?FigureTableID=2567&GroupRefNumber=F0 
1-01
Today in the United States, most occupational exposures 
occur during
•	 Repair,
•	 Renovation, 
•	 Removal, or 
•	 Maintenance
Past Direct
Occupational 
Exposures
of asbestos-containing products installed years ago. The 
Occupational Safety and Health Administration (OSHA)
has estimated that 1.3 million employees in construction
and general industry are exposed to asbestos on the job
during these above-mentioned activities [NIOSH 2011a].
People can also be exposed at home, both to old sources
of asbestos as a result of activities such as home
renovation or to new sources of asbestos as a result of
certain types of recreational activities and hobbies such
as auto repairs and, in areas of naturally occurring
asbestos in local soils, gardening.
In the past, many occupations entailed exposures to
asbestos (see table below). Studies have documented
the scale of the problem.
•	 In the United States, an estimated 27 million
workers were exposed to aerosolized asbestos
fibers between 1940 and 1979 [Nicholson et al.
1982]. These past exposures were heavier than
what workers face today. According to NIOSH, 
current worker exposures exceeding the NIOSH
recommended exposure limit (REL) declined from 
6.3% of workers in 1987−1994 to 4.3% in
2000−2003 [NIOSH 2011a].
Table 3. Occupational Exposure to Asbestos  
Occupations  Businesses  
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• Auto mechanics
• Boilermakers
• Bricklayers
• Building inspectors
• Carpenters
• Demolition workers
• Drywallers
• Electricians
• Floor covering
workers
• Furnace workers
• Glaziers
• Grinders
• Hod carriers
• Insulators
• Ironworkers
• Laborers
• Libby vermiculite
exfoliation plant 
workers
• Longshoremen
• Maintenance
workers
• Merchant marines
• Millwrights
• Operating engineers
• Painters
• Pipefitters
• Plasterers
• Plumbers
• Roofers
• Refinery workers
• Sheet metal 
workers
• Shipyard workers
• Steamfitters
• Tile setters
• U.S. Navy
personnel
• Welders
• Asbestos product
manufacturing 
(insulation, roofing,
building materials)
• Automotive repair
shops (especially
those that involve
repair of brakes,
clutches)
• Construction
companies
• Maritime companies
• Mining companies
• Offshore rust
removal businesses
• Oil refineries
• Power plants
• Railroads
• Manufacturers of
sand or abrasives
• Shipbuilders, ship
lines, and shipyards
• Steel manufacturers
• Tile installation
* Source: NIOSH 2003; 2008
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Past Secondary
Occupational 
Exposure
Secondary exposure occurred when people who did not
work directly with asbestos were nevertheless exposed
to fibers as a result of sharing workspace where others 
handled asbestos. For example, electricians who worked 
in shipyards were exposed because asbestos was used
to coat the ships' pipes and hulls [Pan S et al. 2005].
Past
Paraoccupation 
-al Exposures
In the past, asbestos workers went home covered in 
asbestos dust because of a lack of proper industrial
hygiene. The workers' families and other household 
contacts were then exposed via inhalation of asbestos 
dust:
• From workers' skin, hair, and clothing, and 
• During laundering of contaminated work clothes.
A mortality study of 878 household contacts of asbestos
workers revealed that 4 out of 115 total deaths were 
from pleural mesothelioma and that the rate of deaths
from all types of cancer was doubled [Joubert et al. 
1991]. Also, 11 cases of mesothelioma (6M:5F ratio) 
were diagnosed from 1995−2006 among individuals who
had not worked at the vermiculite operations in Libby,
Montana, but who had some other indirect association 
with those operations. Most had environmental exposure
from living, working, or regularly shopping in Libby
community; two were family members of vermiculite
workers [Whitehouse et al. 2008].
In other environmental exposures [Constantopoulos
2008] asbestos was released into the air and soil around
facilities such as
• Building demolitions,
• Factories handling asbestos,
• Power plants, 
• Refineries, 
• Shipyards, 
• Steel mills, and
• Libby vermiculite mine.
People living around these facilities have been also
exposed to asbestos through their residence close to
asbestos-using industries.
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Current
Occupational 
Exposures
Currently, the people most heavily exposed to asbestos 
in the United States are those in construction trades. 
This population includes an estimated 1.3 million 
construction workers as well as workers in building and 
equipment maintenance [American Thoracic Society
2004]. Because most asbestos was used in construction,
and most asbestos produced is still used in this
industry, risk to these workers can be considerable if the
hazard is not recognized and Occupational Safety and
Health Administration (OSHA) standards are not 
enforced.
Disaster-
Related
Exposures
Responders to the World Trade Center (WTC) disaster
were exposed on an acute short-term basis to an
asbestos-containing mixture of particulate matter
released by the collapsing towers and by rescue,
recovery, and clean-up activities. 
Among the early responders who were exposed short-
term during the hours to days after the collapse were
• Firefighters,
• Police,
• Paramedics,
• Construction workers, and
• Volunteers [Landrigan et al. 2004].
Some people exposed acutely to the high concentrations
of dust released by the towers collapse subsequently
developed reactive airways dysfunction syndrome
(RADS). The U.S. Environmental Protections Agency
(EPA) found that exposure of laboratory mice to WTC
PM2.5 also developed airway irritation [EPA 2002].
Another population potentially exposed to the complex
particulates from the tower collapse was the people
whose residences in nearby buildings were contaminated 
with dust from the WTC collapse.
Public concern about possible health risks faced by this 
population led authorities to study the air quality and 
settled dust in residences near Ground Zero. EPA found 
asbestos fibers greater than 5 microns in length in 0.4%
of settled dust samples (n=22,497) collected from these 
residences [EPA 2005]. At the time of residential air
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sampling for a study by the New York Department of
Health and the Agency for Toxic Substances and Disease
Registry (ATSDR) in November-December 2001 [New 
York City Department of Health and Mental Hygiene and 
ATSDR 2002] total fiber levels (i.e., including asbestos
and all other fibers present) were orders of magnitude
below the occupational exposure limit for asbestos, even 
with aggressive sampling. It was estimated, based on an
extreme worst-case scenario, that someone living for a
full year in an uncleaned residence would have a 1 in
10,000 risk of developing cancer (mesothelioma) due to
that exposure [New York City Department of Health and
Mental Hygiene and ATSDR 2002]. The same authorities
concluded that, with appropriate cleaning of residences,
the dust would present little risk.
Natural disasters can also release asbestos from both 
naturally occurring and man-made sources. An example
of a natural disaster involving the release of naturally
occurring asbestos is the Swift Creek landslide in
Washington State. The rock in this very large, unstable
slope contains naturally occurring asbestos. As it
progressively breaks up over time, slumping and sliding 
into the valley below, it releases asbestos into the
environment, leaving those nearby at risk of exposure
[ATSDR 2008].
An example of a natural disaster releasing man-made
asbestos would be a tornado that releases asbestos into
the environment when it destroys asbestos-containing 
buildings.
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Direct Domestic 
Exposures
As noted previously, some Libby vermiculite home attic
insulation produced before 1990 and many other home
and building materials produced before asbestos was 
banned for fireproofing in 1975 contain asbestos.
•	 People who live in homes with these materials are
at risk of exposure if the materials are loose,
crumbling, and disturbed by household activities or
renovations. 
•	 In such cases, the asbestos materials should be
removed or encapsulated by a trained and certified
asbestos contractor.
•	 For information on where to find certified asbestos
contractors in your state, homeowners should 
contact their local health department.
On the other hand, asbestos contained in intact solid 
material poses a negligible risk of exposure. Air levels of
asbestos in a building with asbestos embedded in 
building materials and undisturbed average 0.0002 f/cc, 
nearly 3 orders of magnitude below OSHA's permissible
exposure limit for occupational exposures [Holland and
Smith 2003].
There are many ways that people can also be exposed to
asbestos through hobbies and recreational activities that
entail contact with materials containing asbestos; some
examples are such activities as home renovation, auto
repair, and urban spelunking. In places where naturally
occurring asbestos is close to the earth's surface,
activities such as gardening and dirt biking can cause
exposures if asbestos-bearing rock is disturbed.
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Exposures at 
School 
Measurable asbestos levels in schools are usually 100 to
1,000 times below OSHA's permissible exposure limit of
0.1 fibers/cc of air for asbestos [Holland and Smith
2003]. However, ATSDR does not use occupational 
standards when considering the risks to health of the
general population from asbestos in the general
environment. A specific environmental health
assessment process is used.
Over time, public concern led to widespread removal and 
abatement programs. Some facilities have higher levels
of airborne asbestos after removal than before,
highlighting the importance of proper encapsulation or
removal by contractors; for if this does not occur, the
levels will be higher post remediation.
Schools are required by EPA to conduct inspections for
asbestos and to follow correct abatement procedures 
using the techniques recommended by EPA. For more
information on how schools should handle asbestos
under the Asbestos Hazard Emergency Response Act
(AHERA), refer to the section in this case study on
standards and regulations.
Background	  
Exposures 	 
No known truly unexposed group exists in the world. The
cumulative risk of background exposures is probably
minor, however, and these concentrations cannot be
reduced [Hillerdal 1999]. Whenever feasible, any source
of pollution that releases significant amounts of asbestos 
fibers should be eliminated, using proper equipment and 
techniques, as soon as it is discovered.
The Libby
Vermiculite
Example
Most vermiculite used today contains low or non-
detectable levels of asbestos. However, the vermiculite
mined in Libby from the 1920s to 1990 was
contaminated with various fibrous amphiboles. The 
amphiboles were comprised of “elongated mineral 
particles identified as a mixture of asbestiform
amphiboles, including winchite, richterite, and tremolite
asbestos” [Virta 2013] and constituted 95% of the
vermiculite used in the United States during that time.
The vermiculite operations in Libby are a good example
of the many ways people can be at risk of asbestos. In
this example, mining of the asbestos- contaminated
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vermiculite ore in Libby resulted in asbestos exposures
to
•	 Vermiculite miners,
•	 Household contacts of miners and Libby vermiculite
plant workers,
•	 Children playing in piles of vermiculite in the area,
•	 Workers who worked in vermiculite exfoliation
plants and other vermiculite handling sites
throughout the United States after it was shipped
there from Libby,
•	 People who live in homes with vermiculite home
insulation, and
•	 Vermiculite transportation routes.
This vermiculite was also used in potting soil, but the
U.S. EPA concluded that consumers “face only a minimal
health risk from occasionally using vermiculite products
at home or in their gardens” [EPA 2000].
For more information about amphibole-contaminated 
vermiculite, see
• 	 ATSDR summary report on 28 priority vermiculite 
exfoliating sites 
at https://www.atsdr.cdc.gov/csem/asbestos_2014 
/images/figure3_USAmap.jpg    
• 	 EPA fact sheet about how to recognize and avoid 
exposure to vermiculite insulation in homes at 
http://www2.epa.gov/asbestos/protect-your­
family-asbestos-contaminated-vermiculite­
insulation 
Key Points •	 Today, the populations most heavily exposed to
asbestos are those in construction trades.
•	 In the past, pipe fitters, shipyard workers, military
workers, automobile mechanics, and people in 
many other occupations were also exposed.
•	 In the past, household contacts of asbestos workers 
were exposed to asbestos dust carried home on 
workers' skin and clothing.
•	 People in homes and buildings with loose,
crumbling, or disturbed asbestos materials can be
exposed to asbestos.
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•	 During renovations or asbestos abatement, 
asbestos materials should be encapsulated or
removed by trained and certified asbestos
contractors.
•	 Asbestos embedded in intact solid materials poses
little risk of exposure as long as it remains intact 
and undisturbed.
•	 Natural outcroppings of asbestos can lead to human 
exposure in a number of ways.
•	 Natural and technological disasters can lead to
asbestos exposure.
Progress Check 5. In the past, occupations that entailed exposure to
asbestos included which of the following?
A. Construction workers, carpenters, sheet metal
workers, and pipe-fitters.
B. Utility workers, boiler-makers, and electricians.
C. Shipyard workers and automobile mechanics.
D. All of the above.
To review relevant content, see “Past Direct
Occupational Exposures” in this section.
6. Of the following, who is most likely to be at risk
from health effects from asbestos exposure?
A. A child attending a school with asbestos-
containing tile flooring.
B. An adult who uses vermiculite potting soil while
gardening.
C. A person who resided with an asbestos worker in 
the 1940s.
D. A family living in a home with intact, solid
asbestos-containing materials.
To review relevant content, see “Direct Domestic
Exposure” and “Exposures at School” in this
section.
What Are U.S. Standards and Regulations for
Asbestos Levels?
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Learning
Objectives
Upon completion of this section, you will be able to
•	 Explain the Occupational Safety and Health
Administration (OSHA) permissible exposure limit  
for asbestos and
•	 Explain the U.S. Environmental Protection Agency's
(EPA) maximum contaminant level for asbestos in 
drinking water.
Introduction	 The earliest evidence of asbestos-associated disease in
workers was found in the 1930s by British studies [Lee 
and Selikoff 1979]. We now know that the toxic effects
of asbestos depend on the nature and extent of
exposure, particularly on the:
•	 Concentration of asbestos fibers involved in the
exposure,
•	 Duration of exposure,
•	 Frequency of exposure,
•	 Type of asbestos fibers involved in the exposure, 
and
•	 Dimensions and durability of the asbestos fibers.
The Center for Disease Control and Prevention/National 
Institute for Occupational Safety and Health (NIOSH)
and OSHA began establishing standards for asbestos in 
the 1970s. U.S. regulatory agencies such as EPA and
OSHA recognize six asbestos and asbestiform minerals, 
i.e., 
•	 Actinolite asbestos, 
•	 Amosite asbestos, 
•	 Anthophyllite asbestos, 
•	 Chrysotile asbestos,
•	 Crocidolite, and
•	 Tremolite asbestos
as legally regulated forms of asbestos out of the group 
of asbestiform minerals. 
Asbestiform minerals are defined as crystal aggregates
displaying these characteristics: groups of separable,
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long, thin, strong, and flexible fibers arranged in parallel 
[ATSDR 2001a].
Currently there is discussion underway to include
as regulated substances asbestiform minerals that
may have similar health effects to the previously 
mentioned forms of asbestos. However, nothing
has been finalized at this time [OSHA 1992; 
NIOSH 2011a].
Currently, there are standards for asbestos in
•	 Drinking water,
•	 Schools,
•	 Some consumer products, and
•	 Workplace air.
Occupational 
Standards
In 1986, OSHA in Standard 29 CFR 1910.1001 
established the current permissible exposure limit (PEL) 
for asbestos in the workplace: (0.1 fibers/cc of air as a 
time weighed average) [OSHA 2012]. PELs are allowable
exposure levels in workplace air averaged over an 8­
hour shift of a 40 hour workweek. There are also OSHA
standards (29 CFR 1915.1001) for shipyards and 
construction (1926.1101).
Additionally, OSHA standards (1915.1001 and
1926.1101) requires employers of all workers whose
work exposes them to asbestos above the PEL or 
excursion limit (1.0 f/cc over 30-minute period) to
•	 Provide training in the engineering controls, work
practices, and proper use of personal protective
equipment (PPE),
•	 Train workers in safety before beginning work and 
annually,
•	 Train workers regarding the health effects of 

asbestos exposure, and
 
•	 Inform workers of the relationship between 
smoking, asbestos exposure and increased risk of
lung cancer.
41
 
 
 
  
  
 
 
    
 
 
 
 
 
   
  
   
 
 
 
  
   
Environmental
Standards
In addition, OSHA requires employers of workers who 
are exposed to asbestos above the PEL and who are 
employed in certain asbestos industries to 
• 	 Provide and make sure of correct use of PPE 
(respirators, protective clothing like coveralls and 
goggles), 
• 	 To undergo medical surveillance in order to identify 
those with signs of asbestos-associated disease, 
remove them from further exposure, 
• 	 Comply with regulations requiring documentation 
for work-related injury claims, and 
• 	 Provide information to workers about where they 
can go for help to stop smoking. 
Components of the required medical surveillance include 
• 	 Chest radiograph, 
• 	 Physical examination, 
• 	 Spirometric test, and 
• 	 Standard questionnaire. 
Further information about OSHA requirements is
available at 
http://www.osha.gov/SLTC/asbestos/standards.html
For further information about protection guidelines,
contact NIOSH via 1-800-CDC-INFO or via
http://www.cdc.gov/niosh/contact/
ATSDR does not consider the use of OSHA's PEL for 
workplace exposures to be appropriate for 
environmentally exposed populations since residential
and/or environmental exposures are 24 hours a day year
round, much longer than the typical 8-hour day and 40­
hour workweek exposures of workers. Children and the 
elderly, who are not typically exposed in the workplace, 
may be more susceptible to exposure.
EPA has established a maximum contaminant level 
(MCL) for asbestos in drinking water of 7 MFL (million
fibers per liter > 10 µm in length) in drinking water [EPA 
2011]. Asbestos in drinking water comes from two main 
sources:
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1. Decay of water mains constructed of asbestos-

containing cement, and
 
2. Erosions of naturally occurring asbestos deposits 
into watersheds [EPA 2012a].
In addition, EPA has
•	 Banned spraying of asbestos in building interiors
(for fireproofing and ceilings),
•	 Developed guidelines for proper treatment of in-
place asbestos in old buildings,
•	 Recommended “no visible emissions” of asbestos,
•	 Regulated demolition of buildings with asbestos
(NESHAP rules), and
•	 Regulated uses of asbestos in industrial products
and construction.
More information on EPA rules and regulations regarding 
asbestos is available at
http://www2.epa.gov/asbestos/asbestos-laws-and­
regulations
Schools	 The Asbestos Hazard Emergency Response Act of 1982
(CFR 40, Part 763, Subpart E) requires that local 
education agencies
•	 Inspect schools for asbestos-containing material
using certified inspectors,
•	 Analyze these materials for asbestos content,
•	 Post results and notify parents and employees if
asbestos is found,
•	 Test air levels following clean-up,
•	 Develop appropriate management plans,
•	 Communicate openly about any asbestos
abatement needed, and
•	 Maintain appropriate records [EPA 2012c].
EPA also warned school authorities that power buffing
and power stripping of asbestos-tile floors in schools
produces significant airborne asbestos levels. Floor
maintenance must be performed by hand to prevent
release of asbestos fibers.
Key Points •	 OSHA's PEL for asbestos in the workplace is 0.1
fibers/cc of air (8-hour TWA).
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•	 OSHA requires all asbestos-exposed workers to be
trained in PPE; they must undergo medical
surveillance if exposed above the PEL.
•	 EPA's MCL for asbestos in drinking water is 7 MFL
greater than 10um in length (million fibers per liter) 
of drinking water.
•	 Local education agencies must inspect schools and 
analyze friable material for asbestos content, 
communicate results, and maintain records.
Progress Check 7. OSHA's PEL for asbestos in the workplace is
A. 10 fibers/cc of air (8-hour TWA).
B. 1 fiber/cc of air (8-hour TWA).
C. 0.1 fibers/cc of air (8-hour TWA).
D. 0.01 fibers/cc of air (8-hour TWA).
To review relevant content, see “Occupational
Standards” in this section.
8. EPA's MCL for asbestos in drinking water is
A. 0.07 fibers per liter of drinking water.
B. 7 million fibers per liter of drinking water.
C. 700 fibers per liter of drinking water.
D. 70,000 fibers per liter of drinking water.
To review relevant content, see “Environmental
Standards” in this section.
What Is the Biological Fate of Asbestos?
 
Learning Upon completion of this section, you will be able to
Objectives
•	 Identify where asbestos fibers are most likely to be
retained in the body.
Introduction	 Inhaled asbestos fibers are deposited in the upper and 
lower respiratory tracts. The durability and retention of 
the fibers in lung tissue and elsewhere in the body may
lead to a risk of disease.
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Deposition in	 Asbestos particles occur in many sizes in inhaled air.
Lungs	 The largest size asbestos particles tend to deposit on the
nasal mucosa or the oropharynx and are sneezed out or 
swallowed and never reach the lungs [NIOSH 2011a].
Some of the smaller inhaled asbestos fibers are
deposited on the surface of the larger airways where
some of them are cleared by mucociliary transport and 
swallowing. Other smaller fibers are deposited further
down in the lung, especially in the bifurcations of the
tracheobronchial tree, and some are deposited in the
alveolar sacs [Broaddus 2001].
There has been much scientific discussion about how
fiber size affects the pathogenicity of asbestos. It is 
believed that the dimensions of the asbestos fiber
determines how far into the lungs it is likely to be
deposited and how quickly it is cleared. Wide fibers
(diameter greater than 2 to 5 microns) tend to be
deposited in the upper respiratory tract and cleared.
Some recent papers have shown cumulative fiber
exposure to be an important risk factor for the
development of asbestosis [Larson et al. 2010a].
However, it is important to remember that asbestos
fibers of all lengths cannot be excluded as contributors
to asbestos-related diseases [Dodson et al. 2003].
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Fate in Lungs Once deposited in the lungs, asbestos fibers are subject
to several lung defenses.
•	 The most important means of removal of insoluble
asbestos particles deposited in respiratory tract
airways is by mucociliary clearance. This cleared
material is usually swallowed and enters the
gastrointestinal tract; however, the asbestos 
coughed out in sputum is eliminated from the body
[NIOSH 2011a].
•	 The most important means of removal of insoluble
asbestos particles deposited in the alveoli involves
alveolar macrophages. These specialized cells 
generally function to clear particles depositing in
the alveoli by enveloping them in a process called 
phagocytosis and then moving to the airways,
where the particle-containing macrophages are
transported out of the lungs via mucociliary
clearance.    
In some cases, insoluble particles are not easily cleared
from the alveoli by alveolar macrophages.
•	 Some (e.g., crystalline silica) particles are highly
reactive and toxic to the macrophage cells, which
die before they can clear the engulfed particles. 
•	 Under “overload” conditions so many particles are
inhaled that they overwhelm the ability of alveolar
macrophages to clear them from the alveoli.
•	 With increasing particle dimension greater than 
about 15 microns, phagocytosis by macrophages
becomes increasingly ineffective. The inability of
macrophages to engulf such particles results in
“frustrated phagocytosis” [NIOSH 2011a].
Some asbestos fibers deposited in alveoli make their
way to the lymphatic system of the lungs, which helps
clears fibers from the lungs [Dodson et al. 2003]. Still, 
many asbestos fibers are retained in lung tissue for
many years. The total burden of residual fibers in the
lungs depend not only the size of the fibers but the
amount of fibers inhaled from the environment
[Dodson et al. 2003].
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Figure 4. Asbestos fiber retained in lung tissue
Movement Out	  
of Lungs 	 
From the lungs, some asbestos fibers (mainly short 
fibers) can migrate to pleural and peritoneal spaces,
especially following patterns of lymphatic drainage
[Broaddus 2001]. Their presence in the peritoneum is
more likely if there is a high fiber burden in the lungs.
Half-Life in the	  
Lungs	  
How rapidly the body's defenses can clear asbestos 
fibers from the lungs depends in part on the type of
asbestos. While all types of fibers are retained for many
years in the lungs [ATSDR 2001a], amphibole fibers are
degraded more slowly than serpentine fibers of the
same dimensions [Hillerdal 1999]. 
Fate of 
Ingested
Asbestos
Most ingested asbestos fibers pass through the
gastrointestinal tract unchanged and are cleared in the
feces. A few ingested fibers pass through the walls of
the gastrointestinal tract. Some of these fibers stay in
the peritoneal cavity. Others move into the bloodstream
and into the kidneys, where some are eliminated 
unchanged in the urine.
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Key Points •	 Some inhaled asbestos fibers reach the lungs,
where they become lodged in lung tissue, especially
at bifurcations and in the lower lung fields.
•	 Some fibers move to pleural or peritoneal spaces or 
the mesothelium.
•	 The half-lives of asbestos fibers vary, but some are
retained in the lungs for many years.
•	 Ingested asbestos fibers are usually eliminated
from the body.
Progress Check 9.	 Some inhaled asbestos fibers that reach the lungs
A. Become lodged and are retained in lung tissue.
B. Migrate to other spaces.
C. Are eliminated via phagocytosis.
D. All of the above.
To review relevant content, see “Fate in
Lungs” and “Movement Out of the Lungs” in this
section.
How Does Asbestos Induce Pathogenic Changes?
 
Learning
Objectives
Upon completion of this section, you will be able to
•	 Describe the hypothesis behind the mechanisms
scientists currently believe leads asbestos to induce
pathogenic changes in the lungs.
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Introduction The main determinants of asbestos toxicity are
• Fiber size,
• Biopersistence,
• Chemical composition, and
• Particle surface characteristics [NIOSH 2011a].
The presence of asbestos fibers in the lungs sets off a 
variety of responses leading to inflammation, cell, and 
tissue damage, which can lead to malignant and non­
malignant diseases.
The mechanisms by which asbestos causes disease are
not fully understood. Currently, there are three
hypotheses to account for the pathogenicity of asbestos:
1. Direct interaction with cellular chromosomes,
2. Generation of reactive oxygen species, and
3. Other cell-mediated mechanisms (especially
inflammation).
Asbestos is genotoxic and carcinogenic.
Interaction
with Cellular
Macromolecules
Because of their surface charge, asbestos fibers can
adsorb to cellular macromolecules (proteins, DNA, RNA) 
and cell surface proteins. Binding of asbestos fibers to
these cellular components is believed to induce changes
in macromolecular conformation, thereby affecting 
macromolecule function.
Long asbestos fibers have been shown to interfere
physically with the mitotic spindle and cause
chromosomal damage, especially deletions [Broaddus
2001; ATSDR 2001; National Academy of Sciences 
2006].
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Release of
Reactive 
Oxygen Species
Asbestos fibers in lung and other tissue are also believed
to cause the formation and release of reactive oxygen
species (ROS). That is, when alveolar macrophages
attempt to engulf and fail to digest an asbestos fiber,
they release lysosomal contents into the alveolar space
[NIOSH 2011a]. This “frustrated phagocytosis” can
generate reactive oxygen species (ROS): hydrogen 
peroxide (H202), and the super oxide radical anion (O2-) 
[Kamp and Weitzman 1999, 1997]. All these ROS induce
tumor necrosis factor-alpha (TNF-α). TNF-α is a potent 
inflammatory cytokine currently felt to play an important 
role in pulmonary fibrosis [NIOSH 2011a].
Other Cell-
Mediated
Mechanisms
The presence of asbestos fibers also causes alveolar
macrophages, lung cells, and pleural cells to release
cellular factors (such as leukotrienes, prostaglandins ) 
that lead to multiple cellular processes such as
• Apoptosis,
• Cell and DNA damage,
• Cell proliferation,
• Inflammation, and
• Macrophage recruitment.
The exact role of all these cellular processes in the
formation of fibrosis and malignancy is still being 
defined [Broaddus 2001; Kamp et al. 2002].
Primary Sites	 When inhaled, asbestos fibers tend to deposit in the lung 
Affected	 at the bronchiolar-alveolar duct bifurcations; some are
deposited in the smaller airways and alveolar sacs. From
the lung, some fibers can migrate into the pleural space
by different mechanisms [National Academy of Sciences, 
2006]. 
Biopersistence in the lung and the subsequent tendency
to cause inflammatory changes is based on fiber
durability. In addition to the low ph (4.8) of 
phagocytosis, a fiber is exposed to extracellular fluids in
the lungs (ph =7) which may gradually dissolve it 
[NIOSH 2011a].
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Carcinogenicity	 Asbestos has been designated as a known human
carcinogen by the agencies shown in the table below. All
types of asbestos are carcinogenic, but some scientists 
believe that the amphibole type is more potent in
causing mesotheliomas than the serpentine type
(chrysotile) [IARC 2012]. However, both types can
cause mesotheliomas and lung cancer [ATSDR 2001].
Table 4. Carcinogenicity of Asbestos
Agency Carcinogenicity Description
International 
Agency for
Research on
Cancer (IARC)
1 Known human 
carcinogen
U.S. 
Environmental
Protection
Agency
Group A Known human 
carcinogen
Key Points •	 The three processes hypothesized to account for
asbestos's pathogenicity are
1. Direct interaction with chromosomes,
2. Generation of reactive oxygen species (ROS), 
and
3. Other cell-mediated mechanisms (especially
inflammation induced by TNF-α).
•	 Asbestos induces pathological changes leading to
such outcomes as fibrosis and malignancy.
•	 Asbestos is genotoxic and carcinogenic.
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10.	 Asbestos induces pathogenic changes in lung tissue
via
A. Direct interaction with chromosomes.
B. Generation of active oxygen species.
C. Cell-mediated inflammatory mechanisms.
D. All of the above.
To review relevant content, see “Introduction” in 
this section.
11.	 As a result of its pathogenic actions, asbestos
A. Induces fibrotic changes in lung tissue.
B. Is genotoxic.
C. Is carcinogenic.
D. All of the above.
To review relevant content, see “Introduction” and
“Carcinogenicity” in this section.
What Respiratory Conditions Are Associated with
Asbestos?
Learning Upon completion of this section, you will be able to
Objectives
•	 Describe the most common respiratory conditions
associated with asbestos exposure.
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Introduction	 According to the American Thoracic Society [2004], 
“asbestos has been the largest cause of occupational
cancer in the United States and a significant cause of
disease and disability from nonmalignant disease.” It
has been estimated that the cumulative total number of
asbestos-associated deaths in the United States may
exceed 200,000 by the year 2030 [Nicholson et al. 
1982].
Depending on the level and duration of exposure,
inhalation of asbestos fibers can cause different diseases 
such as
•	 Asbestosis,
•	 Asbestos-related pleural abnormalities,
•	 Lung and laryngeal carcinoma, and/or
•	 Malignant mesothelioma of the pleura or
peritoneum.
Any combination of these diseases can be present in a
single patient. Clinically, it is important to distinguish
nonmalignant conditions from malignant diseases;
differential diagnosis will be discussed further in later
sections of this document.
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Asbestosis	 Asbestosis is a diffuse interstitial fibrosis of lung tissue
resulting from inhalation of asbestos fibers. Asbestos
fibers inhaled deep into the lung become lodged in the
tissue, eventually resulting in diffuse alveolar and 
interstitial fibrosis. The fibrosis usually first occurs in the
respiratory bronchioles, particularly in the subpleural
portions of the lower lobes. The fibrosis can progress to 
include the alveolar walls. Fibrosis tends to progress
even after exposure ceases [Khan et al. 2013]. This
fibrosis can lead to
•	 Reduced lung volumes,
•	 Decreased lung compliance,
•	 Impaired gas exchange,
•	 Restrictive pattern of impairment,
•	 Obstructive features due to small airways disease,
and
•	 Progressive exertional dyspnea with an insidious
onset.
Asbestosis is characterized by the following radiographic
changes: fine, irregular opacities in both lung fields
(especially in the bases) and septal lines that progress 
to honeycombing and sometimes, in more severe
disease, obscuration of the heart border and hemi­
diaphragm―the so-called shaggy heart sign [Khan et al. 
2013]. Radiographic changes depend on the
•	 Duration, 
•	 Frequency, and 
•	 Intensity of exposure.
Figure 5. Chest radiograph
of asbestosis in the lung
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Patients with asbestosis may have elevated levels of
antinuclear antibody and rheumatoid factors and a 
progressive decrease in total lymphocyte count with 
advancing fibrosis.
Asbestosis has no unique pathognomonic signs or
symptoms, but diagnosis is made by the constellation of
clinical, functional, and radiographic findings as outlined 
by the American Thoracic Society [American Thoracic 
Society 2004]. These criteria include
•	 Sufficient history of exposure to asbestos,
•	 Appearance of disease with a consistent time
 
interval from first exposure,
 
•	 Clinical picture such as insidious onset of dyspnea 
on exertion, bibasilar end-inspiratory crackles not 
cleared by coughing,
•	 Functional tests showing restrictive (occasionally
obstructive) pattern with reduced diffusing capacity
(DLco),
•	 Characteristic radiographic appearance, and
•	 Exclusion of other causes of interstitial fibrosis or
obstructive disease such as usual interstitial
pneumonia, connective tissue disease, drug-related
fibrosis [American Thoracic Society 2004; Khan et 
al. 2013].
The table below describes the natural history associated
with asbestosis.
Table 5. Natural History of Asbestosis
Parameter Typical Findings
Sufficient exposures Usually associated with
high-level occupational 
exposures [Khan et al. 
2013].
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Latency periods Radiographic changes: 
commonly <20 years. 
Clinical manifestations: 
commonly 20-40 years. 
Asbestosis appears 
earliest in those with the 
highest exposure levels 
[American Thoracic 
Society 2004]. 
Risk of asbestosis Asbestosis develops in 
around 50% of adults 
with occupational 
asbestos exposure 
[Khan et al. 2013]. 
Co-morbid conditions Increased risk for 
asbestos-related lung 
cancer and 
mesothelioma, though 
both can occur without 
asbestosis [Weiss 
1999; Hillerdal 1999]. 
Mortality and Morbidity Severe asbestosis may 
lead to respiratory failure 
over 1-2 decades. Many 
patients with asbestosis 
die of other causes such 
as asbestos-associated 
lung cancer (38%), 
mesothelioma (9%), and 
other causes (32%) 
[Rosenberg 1997, Kamp 
 
and Weitzman 1997]. 
Asbestos-
Related Pleural 
Abnormalities
Asbestos-related pleural abnormalities encompass four
types of pleural changes.
1. Pleural plaques.
2. Non-malignant asbestos pleural effusions.
3. Diffuse pleural thickening.
4. Rounded atelectasis (folded lung).
The pleura are more sensitive to asbestos than the lung 
parenchyma, so the effects of asbestos exposure show
56
 
 
 
 
   
   
   
       
     
   
 
 
  
 
    
  
 
 
   
 
  
  
   
 
  
  
  
here first and occur at much lower doses than the 
fibrotic changes in the lung [Peacock et al. 
2000; Khan et al. 2013].
Figure 6. Chest radiograph showing
bilateral pleural plaques
Pleural plaques are well-circumscribed areas of
thickening, usually located bilaterally on the parietal 
pleura. They are usually asymptomatic, though they can 
cause small reductions in lung function [American
Thoracic Society 2004]. On rare occasions (<1%), 
pleural plaques can cause pleuritic pain requiring 
medical pain management [Harbut 2007; Harbut et al. 
2009]. Pleural plaques are the most common 
manifestations of asbestos exposure; by occupation, the
highest rate (58%) has been reported in insulation
workers [American Thoracic Society 2004; Peacock et 
al. 2000]. The presence of pleural plaques in the general
environmentally exposed population in developed 
societies is in the range of 0.5%-8% [Khan et al. 2013]. 
Indeed, they are considered a biomarker of asbestos
exposure, depending more on length from first
exposure, than on cumulative exposure [Peacock et al. 
2000]. Pleural plaques can also form following exposure
to
• Ceramic fibers,
• Talc,
• Silicates,
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•	 Erionite, a rare zeolite [Finkelstein 2013; Clark et 
al. 2006; Zenden et al. 1997].
Non-malignant asbestos pleural effusions are small and 
often bloody unilateral effusions [Khan et al. 2013]. 
These effusions are among the earliest manifestations of
asbestos exposure; they can occur within 10 years of
exposure [Chapman et al. 2003]. They are usually
asymptomatic. Rarely, they can cause pain, fever, and
dyspnea. These effusions typically last for months, and
may occasionally recur. Their presence can precede the
occurrence of diffuse pleural thickening [Chapman et al. 
2003].
Diffuse pleural thickening is a non-circumscribed fibrous
thickening of the visceral pleura with areas of adherence
to the parietal pleura and obliteration of the pleural
space. It can be associated with more extensive
asbestos exposure than pleural plaques [Chapman et al. 
2003]. And, diffuse pleural thickening, in fact, has been
reported to occur in 10% of patients with asbestosis
[Khan et al. 2013]. Diffuse pleural thickening can occur
after non-malignant pleural effusions. The fibrotic areas
are ill-defined, involving costophrenic angles, apices, 
lung bases, and interlobar fissures. Diffuse pleural
thickening can be associated with mild (or, rarely, 
moderate to severe) restrictive pulmonary function
deficits such as decreased ventilatory capacity. When
this occurs, the patient may experience progressive
dyspnea and chest pain [Chapman et al. 2003].
Rounded atelectasis (or folded lung) occurs when 
portions of lung tissue are caught in bands of fibrous
pleural tissue with in-drawing of the bronchi and vessels
[Khan et al. 2013]. This produces a distinctive
radiographic appearance: a rounded pleural mass with 
bands of lung tissue radiating outwards. This condition is
usually asymptomatic, though some patients develop 
dyspnea or dry cough. The course is usually stable or
slowly progressive. Folded lung is the least common 
asbestos-related non-malignant pleural disease; it is not 
only associated with asbestosis exposure but can occur
following other exposures and medical conditions.
However, asbestos exposure is the leading cause of 
58
 
 
 
 
  
  
   
   
 
 
   
   
   
   
   
  
   
    
  
  
   
   
 
   
  
 
 
  
 
 
 
rounded atelectasis, accounting for 29%-86% of cases.
It can rarely also co-occur with lung cancer
[Stathopoulos et al. 2005].
The differential causes of rounded atelectasis includes
•	 Exposure to mineral dusts such as asbestos, and
occupational exposures to silica and mixed mineral 
dusts;
•	 Exudative pleural effusions such as
o	 Empyema,
o	 Tuberculous effusions,
o	 Hemothorax,
o	 Post-cardiac surgery,
o	 Chronic hemodialysis; and
•	 Other medical conditions such as
o	 Legionella pneumonia,
o	 Histoplasmosis, 
o	 End-stage renal disease, 
o	 Pneumothorax, and
o	 Childhood cancer [Stathopoulos et al. 2005].
The table below shows typical findings and natural history associated
with asbestos-related non-malignant pleural abnormalities.
Table 6. Natural History and Findings of Asbestos-related
Pleural Abnormalities
Parameter Pleural 
Plaques
Pleural 
Effusions
Diffuse
Pleural 
Thickening
Rounded 
Atelectasis
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Typical Can occur Usually May occur
Exposures with short 
low-level 
exposures or 
high-level 
occupational 
exposures.
associated
with
moderate-
to high-
level 
exposures.
Less 
specific for
asbestos 
exposure
than  
pleural 
plaques
with
occupational  
and 
environment­
al exposures.
Has other
causes 
besides
asbestos 
exposure.
Average
Latency
Periods
20–30 years 10 years 15 years N/A
Co-morbid Since the Other Other Follows non-
Conditions presence of
these 
plaques is an 
indicator of
asbestos 
exposure,
there is an
increased
incidence of
asbestos-
related
diseases 
associated
with them.
asbestos-
related
diseases.
asbestos-
related
diseases.
Can follow
non­
malignant
pleural 
effusions.
malignant
pleural 
effusions; 
can co-exist 
with other
asbestos-
related
diseases or
its other
causes.
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Mortality Not Not fatal. Not fatal. If Not fatal. 
and fatal/usually Clinical severe, can Usually 
Morbidity asymptoma­
tic;
incidental
finding.
presenta­
tion
ranges
from
asympto­
matic to
pleuritic
chest pain 
and fever.
cause
dyspnea.
Usually no
significant 
functional
impairment
unless very 
extensive.
asympto­
matic; if
severe, chest
pain, 
dyspnea, and 
cough. 
Usually no
functional
impairment
unless
accompanied 
by other
asbestos-
related
disease.
Source: American Thoracic Society 2004; Chapman et al. 
2003; Khan et al. 2013; Stathopoulos et al. 2005
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Lung Carcinoma Most lung cancers are associated with exposure to
tobacco smoke. According to the 2004 Surgeon General
Report on smoking, men with a lifetime of smoking have
a 16 percent higher risk of dying from lung cancer over 
their lifetimes than those who do not smoke [Surgeon 
General 2004] Lung cancer currently accounts for 28%
of all cancer deaths in the United States [Minna 2005].
Exposure to asbestos is associated with all major
histological types of lung carcinoma (adenocarcinoma,
squamous cell carcinoma, and small-cell carcinoma). It 
is estimated that 4%-12% of lung cancers are related to
occupational levels of exposure to asbestos 
[Henderson et al. 2004. It is estimated that 20%-25% 
of heavily exposed asbestos workers will develop
bronchogenic carcinomas [Khan et al. 2013]. Whether
asbestos exposure will lead to lung cancer depends on 
several factors:
•	 Level, duration, and frequency of asbestos
exposure (cumulative exposure) [Henderson et al. 
2004],
•	 Time elapsed since exposure occurred,
•	 Age when exposure occurred,
•	 History of tobacco use, and
•	 Individual susceptibility factors not yet determined.
Most asbestos-related lung cancers reflect the dual
influence of asbestos exposure and smoking 
[Henderson et al. 2004]. It has been known for over 25
years, that smoking and asbestos exposure have a 
multiplicative effect on the risk of lung cancer [Lee 
2001; Henderson et al. 2004; ATSDR 2001]. The 
presence of asbestosis is an indicator of high-level 
asbestos exposure, but lung cancer can occur without
asbestosis.
One of the best known sets of criteria to guide the
clinician regarding whether asbestos contributed to lung 
cancer in an asbestos-exposed individual is the Helsinki
criteria. For these criteria, some of the markers for 
attributing asbestos exposure as a contributing factor to
lung cancer are
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•	 The presence of asbestosis – serves as marker for
significant exposures to asbestos,
•	 Estimated cumulative exposure to asbestos of at 
least 25 fiber-years (if known),
•	 By history, at least 1 year of heavy occupational
exposure or 5-10 years of moderate exposure, and
•	 Lag time of at least 10 years since first exposure
[Henderson et al. 1997].
The table below shows typical findings associated with
lung carcinoma.
Table 7. Findings Associated with Lung
Carcinoma
Parameter Typical Findings
Typical 
exposures
Large cumulative exposure (short­
term, high-level exposures or long­
term, moderate-level exposures).
Latency periods 20–30 years.
Clinical 
presentation
Only 5%-15% of patients are 
asymptomatic when diagnosed. Most
present with cough, hemoptysis,
wheeze, dyspnea [Minna 2005].
Co-morbid 
conditions
Asbestosis, other asbestos-related
diseases. Paraneoplastic syndromes 
associated with lung cancer.
Mortality Same as lung carcinoma with other
causes - 14% five-year survival rate
[British Thoracic Society 2001].
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Pleural 
Mesothelioma 
Diffuse malignant mesothelioma is a tumor arising from
the thin serosal membrane of the body cavities:
• Pleura, 
• Peritoneum,
• Pericardium,
• Tunica vaginalis testis, and
• Outer surface of ovaries. 
It is a rare neoplasm, accounting for less than 5% of
pleural malignancies. There are three histological types
of malignant mesothelioma:
1. Epithelial, 
2. Mixed, and 
3. Sarcomatous.
Of malignant mesotheliomas, 80% affect the pleura, and
20% of all malignant mesotheliomas affect the
peritoneum [Khan et al. 2013]. A 2003 report of
mesothelioma incidence in Australia reported pleural
mesotheliomas at 93.2%, peritoneal mesotheliomas at 
6.5% and mesotheliomas of other rare sites at 0.3% 
[Leigh and Driscoll 2003]. Peritoneal mesothelioma is
discussed in the next section.
In most cases of pleural mesothelioma, the tumor is
rapidly invasive locally [Lee et al. 2000]. Patients with
malignant pleural mesothelioma can have sudden onset
of pleural effusion and/or pleural thickening, dyspnea, 
and chest pain. By the time symptoms appear, the
disease is most often rapidly fatal [British Thoracic 
Society 2001].
Pleural mesothelioma is a signal tumor for asbestos
exposure; other causes are uncommon. The risk of
mesothelioma depends on the amount of asbestos
exposure [Weill et al. 2004]. All types of asbestos can
cause mesothelioma, but some researchers believe that
the amphibole form is more likely to induce
mesothelioma than the serpentine form [ATSDR 2001a].
In 2007, about 2,700 people in the United States died of
mesothelioma [NIOSH 2012a]. According to the National 
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Cancer Institute's Surveillance Epidemiology and End 
Results [SEER] data, there was an increase in the 
incidence of mesothelioma in the United States from the 
early 1970s to the mid-1990s, as disease developed in 
people exposed during peak asbestos exposure years 
(1940–1970). Mesothelioma incidence has probably 
started to decline in the United States, although it may 
still be increasing in Europe and Australia because of 
more abundant and prolonged use of asbestos in these 
countries than in the United States [Weill et al. 2004]. 
The table below shows typical findings associated with 
pleural mesothelioma. 
Table 8.  Findings Associated with Pleural 
Mesothelioma 
Parameter Typical Findings 
Typical exposures Short-term, high-level 
exposures or chronic low-
level exposures, 
especially to amphibole 
asbestos; incidence 
increases in dose-related 
manner [Hillerdal 1999]. 
Latency periods 10–57 years (30–40 
years typical). 
Clinical presentation Frequently presents with 
chest pain accompanied 
by pleural mass or pleural 
effusion on chest 
radiograph [Thoracic  
Society 2001].  
Mortality High. The typical 1-year 
survival rate is <30%. 
Median survival time is 
8–14 months after 
diagnosis [British 
 
Thoracic Society 2001]. 
 
 
Key Points • 	 Asbestosis is an interstitial pulmonary fibrosis 
resulting from inhalation of asbestos fibers. It 
produces a restrictive pattern of disease and 
progressive exertional dyspnea. 
• 	 Asbestos-related pleural abnormalities include 
o 	 Pleural plaques,  
o 	 Non-malignant pleural effusions,  
o 	 Diffuse pleural thickening, and  
o 	 Rounded atelectasis.  
They are relatively benign conditions, though 
diffuse pleural thickening can cause restrictive 
deficits. 
• 	 Lung carcinoma caused by asbestos exposure is 
histologically similar to lung cancer from other 
causes. 
• 	 Malignant pleural mesothelioma is a rare tumor 
arising from the pleural mesothelium. It is a signal 
tumor for asbestos exposure. 
• 	 Asbestos-associated respiratory diseases have long 
latency periods: 10 to 40 years or more, depending 
on the disease and exposure factors. 
Progress Check 12. 	 Diffuse interstitial fibrosis resulting from inhalation 
of asbestos and producing restrictive lung disease 
and progressive exertional dyspnea is termed 
A. Lung carcinoma. 
B. Pleural mesothelioma. 
C. Asbestosis. 
D. Asbestos-related pleural abnormalities. 
To review relevant content, see “Asbestosis” in this 
section. 
13. Asbestos-related non-malignant pleural 
abnormalities include which of the following 
A. Pleural plaques. 
B. Pleural effusions and diffuse pleural thickening. 
C. 	 Rounded atelectasis. 
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D. All of the above.
To review relevant content, see “Asbestos-Related
Pleural Abnormalities” in this section.
What Other Health Conditions Are Associated with
Asbestos?
Learning Upon completion of this section, you will be able to
Objectives
•	 Identify non-respiratory conditions that might be
associated with exposure to asbestos.
Introduction	 Evidence indicates that exposure to asbestos leads to
conditions outside the respiratory system, including
•	 Peritoneal mesothelioma,
•	 Other extra-thoracic cancers, and
•	 Cardiovascular conditions secondary to pulmonary
fibrosis.
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Peritoneal 
Mesothelioma
Peritoneal mesothelioma is similar to pleural 
mesothelioma except that it arises in peritoneal 
membranes. Like pleural mesothelioma, this tumor is
rapidly locally invasive and often rapidly fatal after it is
diagnosed.
Peritoneal mesothelioma is rare. In men, 90% of all 
mesotheliomas are pleural [Weill et al. 2004]. In
addition, the sex difference in incidence is smaller with
peritoneal mesothelioma than for pleural mesothelioma
[Hillerdal 1999].
The table below shows male to female incidence ratios
for the two different types of mesothelioma.
Table 9. Sex Ratios for Different Types of
Mesothelioma
Type of Mesothelioma Male:Female Incidence
Ratio
Pleural 5:1
Peritoneal 1.5:1
Source: Hillerdal 1999
Other Extra-
thoracic
Cancers
Researchers and regulators have not been able to reach
a consensus on the effects of asbestos on extra-thoracic 
cancers. Both the Institute of Medicine (IOM) and the
International Agency for Research on Cancer (IARC)
have reviewed the state of the evidence regarding the
role of asbestos in causing selected extra-thoracic 
cancers. The recent IARC panel determinations are
presented below.
Table 10.  Other Extra-thoracic Cancers
Type of Cancer Evidence for Causality
by Asbestos
Laryngeal Sufficient evidence for
increased risk in asbestos-
exposed workers
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Ovary Sufficient evidence for 
increased risk in asbestos-
exposed women 
Pharyngeal Evidence for associated 
risk from asbestos 
exposure is suggestive but 
not sufficient. More 
research is needed. 
Stomach Evidence for associated 
risk from asbestos 
exposure is suggestive but 
not sufficient.   
Colorectal Evidence for risk from 
asbestos exposure is 
suggestive but not 
sufficient. More research 
is needed. The IARC 
working group was evenly 
divided on whether the 
evidence was sufficient to 
designate causality. 
Esophageal Inadequate evidence 
exists to determine the 
risk from asbestos 
exposure. 
Source: IARC 2012 
Despite the lack of scientific consensus on the role of
asbestos in gastrointestinal cancers, ATSDR and the
National Toxicology Program (NTP) concur that it is
prudent to consider increased risk of gastrointestinal
cancer a possible effect of asbestos exposure [ATSDR
2001a; American Thoracic Society 2004; National
Toxicology Program 2011]. Colon cancer screening 
starting at age 50 is recommended using accepted 
guidelines [Agency for Healthcare Research and Quality,
2008] but on the basis of current evidence, screening for
other extrathoracic cancers in people exposed to
asbestos is not currently recommended [American
Thoracic Society 2004; Griffith and Maloney 2003].
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Cardiovascular	  
Conditions 	 
Cor pulmonale occurs in many forms of far advanced 
lung disease when fibrosis of the lungs leads to
increased resistance to blood flow through the capillary
bed. This condition is most commonly seen in patients
with severe asbestosis, though it can also occur with less
severe fibrotic disease, especially if chronic obstructive
pulmonary disease is simultaneously present, as is often 
the case with asbestos workers who have been smokers.
Constrictive pericarditis rarely occurs secondary to
severe asbestos-induced fibrosis or calcification of the
pericardium.
Key Points •	 Pleural and peritoneal mesothelioma is a rare, 
rapidly invasive tumor caused by asbestos 
exposure.
•	 Asbestos exposure is a known risk factor for
laryngeal cancer and ovarian cancer.
•	 Asbestos exposure might be associated with some
other extrathoracic cancers, especially colon cancer.
•	 Cor pulmonale can occur secondary to pulmonary
fibrosis, mainly in patients with severe asbestosis.
•	 Rarely, constrictive pericarditis can occur secondary
to asbestos-associated disease.
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Progress
Checks
14. Exposure to asbestos is indicated by
A. Malignant mesothelioma of the pleura or
peritoneum.
B. Gastrointestinal cancer.
C. Other extra-thoracic cancers.
D. All of the above.
To review relevant content, see “Peritoneal 
Mesothelioma” in this section.
15. The cardiovascular condition most likely to occur
secondary to pulmonary fibrosis is
A. Endocarditis.
B. Constrictive pericarditis.
C. Cor pulmonale.
D. All of the above.
To review relevant content, see “Cardiovascular
Conditions” in this section.
Clinical Assessment
 
Learning
Objectives
Upon completion of this section, you will be able to
•	 Identify the primary focuses of the patient exposure
history (exposure and medical) and
•	 Describe the most typical finding on examination of 
asbestosis patients.
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Introduction	 Patients who have been significantly exposed to
asbestos should undergo a thorough medical evaluation.
Early and accurate diagnosis is important to your
choosing the most appropriate care strategies, even if
the patient is not exhibiting symptoms. In cases of
asbestos exposure, medical evaluation should include
•	 An assessment of clinical presentation,
•	 An exposure history (See ATSDR Case Study in
Environmental Medicine: Taking an Exposure
History),
•	 A medical history,
•	 A physical examination, and
•	 A chest radiograph or other imaging and pulmonary
function tests [American Thoracic Society 2004].
This section focuses on the first four items, which are
typically conducted during the patient's visit to your
office. Recommended tests are discussed in the next
section.
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Clinical 
Presentation
Many people with occupational exposure to asbestos
never have serious asbestos-related diseases. However,
asbestos-associated diseases typically have long latency
periods so many patients exposed to asbestos are
asymptomatic for years before any clinically apparent 
asbestos-related disease develops. If and when
asbestos-associated disease does manifest clinically, the
patient's symptoms depend on the type and stage of
disease(s) involved (see table). A single patient can
have any combination of asbestos-associated diseases.
Table 11. Clinical Presentation of Asbestos
Associated Diseases
Asbestos-
Associated
Disease
Clinical Presentation
Asbestosis Presenting Symptoms
• Dyspnea on exertion
• Nonproductive cough
• Fatigue
• Signs
• Wheezing 
• Bibasilar end-inspiratory
rales (i.e., crackles) on 
ausculation of the chest
Advanced Stages.
• Clubbing of the fingers
• Dyspnea at rest
• Cyanosis
• Cor pulmonale (rare)
Asbestos-related
non-malignant
pleural abnormalities
Presenting Symptoms
• Usually none
• In some cases, intermittent
chest pain, rarely can be
severe.
73
 
 
 
 
Lung cancer Presenting Symptoms 
• 	 Early in the course, usually 
none. Sometimes none, if 
cancer is found incidentally 
(e.g., on a chest 
radiograph done for 
another reason). 
• 	 Occasionally, dry cough 
• 	 Advanced Stages 
• 	 Hemoptysis 
• 	 Chest pain, usually severe 
•	  Weight loss 
•	  Fatigue 
•	  Dyspnea (due to pleural 
effusion or obstructive 
pneumonia) 
Mesothelioma Presenting Symptoms 
• 	 Frequently presents with 
chest pain and dyspnea 
Advanced Stages 
• 	 Dyspnea (due to space-
occupying mass and/or 
pleural effusion) 
• 	 Severe and progressive 
chest pain, sometimes 
pleuritic in nature 
• 	 Systemic signs of cancer 
such as weight loss and 
fatigue 
Source: British Thoracic Society 2001; American 
Thoracic Society 2004 
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Exposure 	 
History 	 
Taking a detailed exposure history is an important step
in evaluating a patient who may be at risk for developing
asbestos-associated diseases. In general, risk of
asbestos-related disease increases with total dose
[Khan et al. 2013]. However, since asbestos 
accumulates in the body, even relatively minor
exposures many years in the past could be important in 
diseases like mesothelioma. The exposure history should 
include
•	 Work history, including occupations in which the
patient may have been exposed directly or
indirectly.
•	 Source, intensity, frequency and duration of
exposure.
•	 Time elapsed since first exposure.
•	 If extant, workplace dust measurements or
cumulative fiber dose (or exposure scenario, if
levels cannot be determined).
•	 Use of personal protective equipment.
•	 Other sources of exposure, including 
paraoccupational exposures from family members
and other household contacts.
•	 Sources of environmental exposure, including
residence near an area with naturally occurring 
asbestos deposits or hobbies or recreational
activities that involve materials that contain
asbestos).
•	 Smoking history and sources of other 
environmental contaminants such as environmental
tobacco smoke [American Thoracic Society 2004].
For more information on the exposure history, see the
Taking an Exposure History CSEM at
https://www.atsdr.cdc.gov/csem/csem.asp?csem=33&p 
o=0
See the table below for typical exposures for each of the
asbestos-associated diseases.
Table 12. Estimated Exposures and Disease Risk
for Asbestos
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Asbestos-Related
Disease
Typical Exposure History
Asbestosis Usually associated with
high-level occupational 
exposures, not with
paraoccupational or
environmental exposures
[Khan et al. 2013].
Asbestos-related non­
malignant pleural 
abnormalities
Presence of pleural plaques
depends more on time
from first exposure rather 
than on a threshold dose
[Larson et al. 2010b], but 
the incidence of this
disorder in a population 
does increase with
exposure. Occurs in 0.5% 
to 8% of environmentally 
exposed individuals and up
to 58% of insulation
workers [Peacock et al. 
2000].
Non-malignant pleural 
effusion earliest 
manifestation of asbestos
exposure. They can occur
within ten years of
asbestos exposure.
Diffuse pleural thickening is
associated with more
extensive asbestos 
exposure than pleural
plaques.
Folded atelectasis not only
occurs after asbestos 
exposure but is associated
with other exposures and 
medical conditions.
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Lung cancer Dose-related. Synergistic 
relationship with smoking 
[Jaklitsch et al. 2012]. 
Mesothelioma Not as clearly dose-related 
as other asbestos-related 
diseases, but the risk does 
appear to increase with 
dose. Can be found in 
residents near asbestos 
mines and with 
paraoccupational exposure. 
[British Thoracic Society 
2001]. 
 
Medical History	 Knowing the complete medical history of a patient who
has been exposed to asbestos is important to making an 
accurate diagnosis. It is especially important to ask
about a history of smoking and exposure to
environmental tobacco smoke, because exposure to
tobacco smoke, especially active smoking, can greatly
increase risk of lung cancer and can worsen the effects 
of asbestosis in asbestos-exposed patients.
Particularly for asbestos-related non-malignant diseases, 
it is important to be aware of other respiratory and non-
respiratory conditions that may have similar clinical
presentations in order to rule them out.
Physical 
Examination
Patients with a history of asbestos exposure should
receive a full physical examination with special attention
to the respiratory system. In the case of early or mild
disease, there will probably be no abnormal physical 
findings. The most common abnormal finding with 
significant asbestosis is bibasilar end-inspiratory rales 
(i.e., crackles) on auscultation. These are described as 
sounding like Velcro [Ross 2003].
Physical examination should also include
•	 Examination for clubbing of the fingers and 

cyanosis [American Thoracic Society 2004],
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Differential 
Diagnosis respiratory conditions have symptoms similar to those of 
asbestos-associated diseases. It is important to 
• 	 Examination of the extremities for symmetrical 
dependent edema, one of the physical findings of 
cor pulmonale, 
•	  Abdominal palpitation for abnormal masses or signs 
of peritoneal effusion that can accompany 
peritoneal mesothelioma, and 
•	  Fecal occult blood testing to screen for colorectal 
cancer screening [CDC 2013]. 
Several other non-asbestos related respiratory and non-
distinguish these conditions, for some of which have 
specific treatments different from asbestos-related non­
malignant diseases, for which medical treatment is 
entirely symptomatic (see table). 
It is also important to distinguish non-malignant 
asbestos-associated conditions from malignant 
conditions such as lung cancer and mesothelioma. In 
cases that are not clear cut, a referral to a pulmonary 
specialist for further workup is indicated. 
Table 13. Differential Diagnosis of Respiratory 
Conditions that Can Be Confused with Asbestos-
related Conditions 
Asbestos- Differential Differential 
Related Diagnosis: Diagnosis: Non-
Condition Respiratory Respiratory 
Condition Condition 
Asbestosis • Rheumatoid • Left ventricular 
arthritis and other failure 
connective tissue (presents with 
diseases (with dyspnea, rales, 
pleural or edema, 
pulmonary restriction, and 
involvement) basilar 
markings on 
•	  Other chest film) 
pneumoconiosis: 
o	  Talc 
o	  Titanium 
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o 	 Zeolite 
•	  Interstitial 
pulmonary fibrosis 
(IPF), including 
idiopathic 
pulmonary fibrosis 
•	  Hypersensitivity 
pneumonitis 
• 	 Sarcoidosis 
• 	 Drug-related 
fibrosis 
•	  Other pulmonary 
fibrosis 
Asbestos- Single pleural plaques Prior thoracic 
related surgery/chest 
non­ • 	 Malignant wall 
malignant mesotheliomas configuration 
pleural and metastatic 
disease adenocarcinomas 
[Khan et al. 2013] 
Single calcified 
pleural plaques 
•	  Empyema 
• 	 Hemothorax  
• 	 Tuberculosis 
[Khan et al. 2013] 
Bilateral calcified 
pleural plaques 
• 	 Most commonly 
asbestos-related 
but in rare cases 
o 	 Radiation 
exposure 
o 	 Hyperparathyr 
oidism 
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 o 	 Pancreatitis 
[Khan et al. 
2013] 
Diffuse pleural 
thickening 
• 	 Post-exudative 
effusions such as 
parapneumonic 
effusions and 
those secondary 
to connective 
tissue disease 
•	  Hemothorax 
• 	 Mesothelioma 
[Khan et al. 2013] 
Rounded atelectasis 
(folded lung) 
•	  Lesions that are 
similar in 
appearance to 
rounded 
atelectasis (i.e., 
solitary 
pulmonary mass) 
are 
o 	 Malignancies 
such as 
bronchogenic 
carcinoma, 
metastasis, 
lymphoma 
o 	 Benign 
neoplasms 
such as 
hamartoma 
and adenoma 
o 	 Vascular 
causes such as 
arteriovenous 
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malformation, 
pulmonary 
infarct, 
hematoma 
o 	 Infections such 
as tuberculosis, 
round 
pneumonia, 
fungal 
infections 
[Khan et al. 
2013] 
Lung Other causes of a  
carcinoma solitary pulmonary 
nodule 
• 	 Folded lung  
• 	 Metastatic lesion  
•	  Lymphoma  
• 	 Benign neoplasms 
such as 
hamartoma or 
adenoma  
• 	 Vascular lesion 
such as a 
arteriovenous 
malformation, 
pulmonary 
infarction or 
hematoma  
• 	 Infectious lesions 
from tuberculosis, 
fungal infections 
[Khan et al. 2013]  
Malignant • Diffuse pleural  
mesotheli­ thickening 
oma • 	 Metastatic 
adenocarcinoma 
[Khan et al. 2012; 
British Thoracic 
Society 2001] 
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Key Points •	 The exposure history focuses on finding information 
on exposures to asbestos.
•	 The medical history focuses on smoking history and
other respiratory conditions.
•	 The most typical abnormal finding on examination 
of patients with a history of asbestos exposure is 
bibasilar end-inspiratory rales on auscultation.
•	 Patients with asbestosis present to the clinician with
the chief complaint of insidious onset of dyspnea on 
exertion.
•	 Asbestos-related non-malignant pleural 
abnormalities typically do not cause symptoms,
although some patients experience progressive
dyspnea and chest pain.
•	 Lung cancer can be asymptomatic, but in the later
stages patients experience fatigue, weight loss, 
chest pain, dyspnea, or hemoptysis.
•	 Mesothelioma can be asymptomatic, but patients
usually present in later stages of the disease, at 
which point dyspnea and chest pain are common.
Progress
Checks
16.	 The most typical abnormal finding on physical
examination of a patient with significant asbestosis
is
A. Cyanosis.
B. Bibasilar inspiratory rales on auscultation.
C. Clubbing of the fingers.
D. All of the above.
To review relevant content, see “Physical 
Examination” in this section.
17. Why is it important to know a patient's exposure
 
history?
 
A. Asbestos-associated diseases have symptoms 
similar to those of treatable diseases, and the
exposure history assists a differential diagnosis.
B. Activities such as smoking can increase a 
patient's risk of asbestos-related diseases.
C. Asbestos accumulates in the body and, for
certain disorders, even minor exposures can be
important.
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D. All of the above.
To review relevant content, see “Exposure
History” in this section.
Clinical Assessment – Tests
 
Learning
Objectives
Upon completion of this section, you will be able to
•	 Describe chest radiograph findings associated with 
other asbestos-associated diseases and
•	 Describe pulmonary function test findings
 
associated with asbestosis.
 
Introduction	 The most important tests in diagnosing asbestos-
associated disease are
•	 Chest radiographs and
•	 Pulmonary function tests.
Other tests and procedures that are sometimes used to
diagnose asbestos-associated diseases by specialists in
cases that require further work-up include
•	 Blood studies,
•	 Bronchoalveolar lavage (BAL),
•	 Colon cancer screening.
•	 Computed tomography (CT) or high-resolution, 
computerized (axial) tomography (HRCT), and
•	 Lung biopsy.
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Screening
Pulmonary
Function Tests
Screening pulmonary function tests are useful for finding 
restrictive deficits most commonly associated with
asbestosis (see table). Findings may include a reduction 
in forced vital capacity (FVC) with a normal forced
expiratory volume (FEV) in one second FEV1/FVC ratio. 
Some sources report abnormal pulmonary function tests
in 50% to 60% of patients with asbestosis [Ross 2003].
In some cases, combined patterns of restrictive and
obstructive disease may be seen. For further assessment
of whether a patient has a restrictive abnormality and
asbestosis, additional, more specialized tests may be
required.
•	 Carbon monoxide diffusion capacity (DLco), which 
is very sensitive to ventilation-perfusion mismatch
and gas exchange abnormalities characteristic of all
types of diffuse interstitial pulmonary fibrosis, is
reduced in 70% to 90% of asbestosis cases [Ross 
2003]. Be aware however that low DLco is a non­
specific finding and it can be present in far
advanced stages of chronic obstructive pulmonary
disease (COPD) as well as in other types of
restrictive interstitial diseases.
•	 Static lung volumes measured by plethysmographic
or helium dilution methods.
Consider consulting a pulmonologist if the diagnosis is
unclear, if there is a rapid decline in pulmonary function,
or if there is a potential need for a tissue biopsy or BAL,
such as in cases where lung cancer, mesothelioma, or an 
infection is suspected. The pulmonologist may
recommend more extensive pulmonary function tests.
Table 14. Pulmonary Function Test Results 

Associated with Asbestos-related Diseases
 
Asbestos- Findings
Associated Disease
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Asbestosis Restrictive spirometry 
pattern (i.e., low FVC with 
normal FEV1/FVC ratio. 
Mixed obstructive/restrictive 
spirometry pattern (i.e., 
reduced FEV1/FVC ratio with 
reduced FEV1) [American 
Thoracic Society 2004]. 
Decreased DLco [American 
Thoracic Society 2004]. 
Asbestos-related Normal pattern or if 
pleural abnormalities extensive pleural involvment, 
restrictive spirometry pattern 
[Larson et al. 2012]. 
 
Chest
Radiograph
The chest radiograph is used primarily to find, localize, 
and assess the extent of structural changes associated
with asbestos-caused chest diseases (asbestosis, non­
malignant pleural disease, mesothelioma, and lung 
cancer).
Diagnosis of asbestosis should mostly but not totally be
based on radiographic findings, per the diagnostic
criterion of the American Thoracic Society. In 10% to
15% of cases, an asbestos-associated pulmonary
function abnormality can occur without definite
radiologic change [Ross 2003]. The association of pleural 
thickening and calcification with interstitial changes
enhances diagnostic accuracy of asbestosis.
During the latter half of the past century, the
International Labour Office (ILO) developed a system for 
radiographic classification of the pneumoconiosis. It now
includes a set of standard digital radiographic images or
a set of standard plain film images. [ILO 2011, NIOSH
2011b] Persons certified by the National Institute of
Occupational Safety and Health (NIOSH) as proficient in
the use of this rating system are called "B Readers."
Most epidemiological studies of pneumoconiosis use B
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Readers to classify radiographs according to the ILO
system. 
A current list of B Readers can be found at
http://www.cdc.gov/niosh/topics/chestradiography/brea 
der-list.html. Classification of asbestosis by chest
radiography should be guided by the ILO system.
A list of typical chest radiograph findings for each of the
asbestos-associated diseases is in the table below.
Figure 7. Radiographic images associated with
asbestos-related diseases
Pleural Plaques Pleural 
Mesothelioma
Asbestosis
Table 15. Typical Radiographic Findings for
Asbestos-related Diseases
Asbestos-
Associated
Disease
Typical Chest Radiograph 
Findings
Asbestosis Small, irregular opacities in
both lung fields, predominating 
at the lung bases.
Diffuse, bilateral interstitial 
fibrosis.
With advanced disease,
combined interstitial and
pleural involvement can blur
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the heart border (also known 
as the “shaggy heart sign”).
Honeycombing and upper lobe
involvement in near end-stage
disease.
Asbestos-related
Non-malignant
Pleural 
Abnormalities
Pleural Plaques
Often multiple bilateral well-
circumscribed areas of
thickening found on the pleura,
sometimes with calcification 
(10%-15%) [Khan et al. 2013].
Non-malignant Pleural Effusions
Indistinguishable from other 
pleural effusions, but usually
small and can be either
unilateral or bilateral.
Diffuse Pleural Thickening
Smoothly thickened parietal 
pleura often associated with
obscuration of the costophrenic
angle [Khan et al. 2013].
Sometimes, prominent 
interlobar fissures).
Rounded Atelectasis
Appears as a rounded 
intrapulmonary mass abutting 
on thickened pleura, with
bands of lung tissue radiating 
outwards.
Lung cancer Radiological appearance same
as that of lung cancers with 
other causes (e.g., solitary
pulmonary mass with or
without mediastinal 
lyphadenopathy).
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Mesothelioma May present as a 
• 	 Pleural effusion, 
• 	 Pleural mass, or 
• 	 A diffuse pleural 
thickening. 
 
CT and HRCT	 In some cases, computed tomography (CT) scans,
including high-resolution computed tomography (HRCT)
scans, due to their greater sensitivity and specificity
than conventional chest radiographs [Paris et al. 2009]
can facilitate diagnosis of asbestos-associated diseases
such as lung fibrosis [Vierikko et al. 2010. Because they
are associated with higher doses of radiation than
conventional chest radiographs and their cost-
effectiveness and efficiency as screening tools have not
been established, CT scans are not currently
recommended in the United States for routine screening
of asbestosis of the general population.
They can be useful in further investigating abnormalities
found on chest radiographs and in detecting 
abnormalities not seen on chest films of patients with 
dyspnea or pulmonary function abnormalities such as 
decreased DLco [Vierikko et al. 2010].
CT and HRCT scans are more sensitive and specific than 
chest radiographs. HRCT scans can be used particularly
when abnormalities on a conventional chest radiograph
are equivocal or when a conventional chest radiograph is
normal in the face of unexplained lung function 
abnormalities in a patient with significant asbestos
exposure [American Thoracic Society 2004]. They are 
especially useful in detecting
•	 Early parenchymal abnormalities of asbestosis,
•	 Early pleural disease, such as plaques and rounded 
atelectasis,
•	 The difference between asbestos-associated pleural
plaques and extra-pleural fat, and
•	 Mesothelioma [British Thoracic Society 2001].
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BAL and Lung
Biopsy
However, HRCTs are recommended for use in screening
special populations at high risk of lung cancer such as 
people with smoking histories of 15 to 30 pack years and 
those with some occupational exposures such as
asbestos, arsenic, chromium, silica, nickel, cadmium, 
berryllium and diesel fumes [Bach et al. 2012; NIOSH 
2012b].
The utility of other imaging techniques such as
ultrasound, gallium scanning, magnetic imaging,
ventilation-perfusion studies, and positron emission 
tomography has not been established in asbestos-
related disease. 
Bronchoalveolar lavage (BAL) is sometimes used by
specialists to identify other possible causes for lung
pathology. It can be used to assess exposure to 
asbestos by measuring the amount and type of asbestos
bodies and asbestos fibers in the lavage fluid [American
Thoracic Society 2004]. Not only is this a somewhat 
invasive procedure requiring fiberoptic bronchoscopy,
but the laboratory procedures are not routinely
available; special laboratory facilities and expertise are 
required.
Lung biopsy is a definitive test used in the
histopathological confirmation of asbestos-associated
diseases. Lung biopsies are rarely used to diagnose
asbestosis or pleural plaques, because diagnosis of these
conditions is usually based on medical and exposure
histories, findings from the physical examination, and 
other tests. Appropriate referral to a specialist is
indicated if lung cancer or mesothelioma is suspected, 
since a lung biopsy will be indicated under these
conditions.
Blood Studies Blood studies may occasionally be useful for ruling out 
other causes of restrictive lung disease.
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Colon Cancer
Screening
Evidence increasingly shows that asbestos exposure
increases an exposed patient's risk for colon cancer
[IARC 2012]. Therefore, it is important to perform colon
cancer screening on asbestos exposed patients starting
at age 50 according to current guidelines [Agency for
Health Care Research and Quality 2008].
The joint guidelines from the American Cancer Society, 
the U.S. multi-society task force for colorectal cancer,
and the American College of Radiology can be found at:
http://www.ncbi.nlm.nih.gov/pubmed/18322143 [Levin
et al. 2008].
False Positives It is important to know what other conditions bear
and False radiographic similarities to changes associated with 
Negatives asbestos-related disease (see table).
Table 16. Radiographic Findings that May Be 
Confused with Asbestos-related Diseases 
Asbestos- Similar Radiographic 
Associated Disease Appearance 
Asbestosis • 	 Left ventricular failure. 
• 	 Other forms of 
pulmonary fibrosis, 
including other forms of 
pneumoconiosis. 
Asbestos-related non­ General differential 
malignant pleural diagnoses 
abnormalities 
• 	 Acute infectious pleuritis 
(including empyema 
and pleural 
tuberculosis). 
• 	 Previous surgery or 

chest wall trauma.
  
• 	 Past empyema or
  
infected pleural 

effusion.
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Pleural plaques may be
confused with
• Extra-pleural fat,
• Muscle shadows, 
• Pleural thickening from 
old rib fractures
Non-malignant asbestos-
related pleural effusions may
be confused with
• Malignant pleural
effusion and
• Multiple other causes of
pleural effusion, 
including tuberculosis,
congestive heart failure, 
etc.
Diffuse pleural thickening 
may be confused with
• Mesothelioma,
• Healed empyema,
• Old chest trauma, 
and/or
• Old chest surgery.
Rounded atelectasis
• Bronchogenic
carcinoma.
• Mesothelioma.
• Pleural-based lung 
cancer or metastasis to
the pleura.
Lung cancer Lung cancer not related to
asbestos.
Mesothelioma All other causes of unilateral 
pleural masses.
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Attribution of 
Asbestos-
Related Cause
To help attribute pulmonary fibrosis to asbestos 
exposure, check for the diagnostic guidelines suggested 
by the American Thoracic Society:
•	 Characteristic appearance on radiographic chest
imaging or, when lung tissue is available, tissue
histopathology.
•	 Exposure history (with appropriate latency period); 
and/or asbestos bodies or uncoated fibers found in 
sputum, BAL, or lung tissue; and/or pleural plaques
(as a marker of exposure) and
•	 Other causes unlikely.
•	 Other findings that aid in documenting disease
 
attributable to asbestos exposure include
 
o	 Abnormal spirometry test results (restrictive
and/or obstructive pattern),
o	 Low DLco, and
o	 Ausculatory signs such as characteristic rales 
[Holland and Smith 2003; American Thoracic 
Society 2004].
Bilateral calcified pleural plaques are usually attributable
to asbestos exposure, but unilateral pleural plaques
should motivate a search for other causes such as old
tuberculosis, empyema, or hemothorax. CT scanning is
useful to make a definite diagnosis of rounded 
atelectasis [Khan et al. 2013].
As stated previously, sets of diagnostic criteria like the
Helsinki criteria can help in attributing an individual 
patient’s lung cancer to asbestos exposure.
Malignant mesotheliomas are, for all practical purposes,
readily attributable to past asbestos exposure.
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Key Points •	 Asbestosis is commonly associated with restrictive
patterns on spirometry.
•	 Signs of asbestosis on chest radiograph include
interstitial fibrosis and the “shaggy heart sign.”
•	 On chest radiograph, pleural plaques appear as
well-circumscribed areas of pleural thickening,
sometimes with calcification.
•	 On chest radiograph, pleural effusions caused by
asbestos have the same appearance as effusions
from other causes, though they are typically small.
•	 On chest radiograph, diffuse pleural thickening
appears as a smooth prominence along the chest 
wall and interlobar fissure thickening, often with
obscuration of the costophrenic angle.
•	 On chest radiograph, findings associated with
rounded atelectasis appear as a rounded 
intrapulmonary mass that abuts on thickened 
pleura and has radiating bands of lung tissue.
•	 Asbestos-associated lung cancer has the same
appearance as lung cancer from other causes. 
• 	 Chest radiograph findings associated with 
mesothelioma include pleural effusions or a pleural 
mass. 
• 	 CT and HRCT scans can be useful to clarify 
questionable pleural or parenchymal findings, and 
in diagnosing mesothelioma. 
• 	 Other tests that can be useful include BAL, lung 
biopsy, and colon cancer screening. 
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Progress 18. The two most important tests for diagnosing
Check asbestos-associated diseases are
Questions
A. BAL and lung biopsy.
B. CT and HRCT scans.
C. Chest radiograph and pulmonary function tests.
D. Blood studies and colon cancer screening.
To review relevant content, see “Introduction” in 
this section.
19.	 Diffuse, small, irregular opacities are characteristic
radiographic findings with
A. Asbestosis.
B. Lung cancer.
C. Mesothelioma.
D. All of the above.
To review relevant content, see “Chest 
Radiograph” in this section.
How Should Patients Exposed to Asbestos Be
Treated and Managed?
Upon completion of this section, you will be able toLearning
Objectives
•	 Identify two primary strategies for managing
asbestos-associated diseases and
•	 Describe specific strategies for managing
asbestosis.
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Introduction	 Asbestos-associated diseases such as asbestosis and
pleural plaques are not curable. Some complications of
asbestos-related disease like acute pleuritis are self-
limited. Management focuses on prevention and 
amelioration of symptoms in the patient with asbestos-
related disease. Therefore, the primary actions are to
•	 Avoiding further exposure to asbestos if that is
currently occurring,
•	 If currently employed in a job that entails asbestos 
exposure, the patient should be referred to an 
occupational specialist who can advise the patient 
on avoiding further exposures through the use of
personal protective equipment (PPE) and well 
ventilated work spaces, and can provide important 
advice regarding the legal and occupational issues
that work with asbestos entails, and
•	 Monitor the patient to facilitate early diagnosis and 
treatment of any treatable respiratory conditions
associated with asbestos.
Patients who are symptomatic may need documentation 
of impairments caused by asbestos-associated disease
for the purpose of filing for workers compensation, social 
security disability, or other claims. Explanation of the
specific statute of limitations for filing of workers
compensations should be explained; the different states
will have differing laws regarding workers compensation 
claims. Degree of disability should be stated in the terms
required by the program to which the patient is
applying. Recording these impairments and advising on 
legal issues associated with occupational asbestos-
related disease is an important task and may require the
assistance of a specialist such as an occupational
physician. To locate such a specialist, please refer to the 
Web resources listed under “Sources of Additional 
Information” at the end of this CSEM.
The remainder of this section focuses on patient care.
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All Exposed 
Patients
Care of patients who have been exposed to asbestos,
whether or not they are symptomatic, involves routine
follow up to facilitate early diagnosis and intervention. 
This includes
•	 Exposure and medical histories and regular physical
examinations,
•	 Periodic chest radiographs and pulmonary function 
tests to look for early signs of asbestos-associated
disease,
•	 Encouraging smoking cessation for patients who
smoke, and
•	 Educating patients regarding the possible
 
consequences of asbestos exposure.
 
Asbestosis	 Asbestosis is irreversible, and the rate of disease
progression varies [American Thoracic Society 2004]. 
Currently, there is no specific effective treatment.
Patients with advanced disease and hypoxemia at rest,
during exercise, or during sleep may benefit from
continuous home oxygen therapy, which can prevent or
attenuate cor pulmonale. However, primary
management strategies for asbestosis are listed below.
•	 Remove the patient from the source of exposure if
there is any ongoing exposure. If occupational
exposure is currently ongoing, refer the patient to
an occupational physician for advice on achieving 
cessation or amelioriation of this occupation related
issue.
•	 Assess the patient's level of disability.
•	 Treat chest infections aggressively.
•	 Provide pneumococcal vaccine and annual influenza
vaccines as recommended by Centers for Disease
Control and Prevention.
•	 Provide respiratory therapies and pulmonary
rehabilitation as needed.
•	 Counsel patients who smoke to quit.
•	 Counsel patients to call you if they notice any
changes in their health such as weight loss, change
in cough, coughing up blood.
•	 Notify the appropriate health authorities in states
where asbestosis is reportable.
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Pleural 
Abnormalities
• Follow the general strategies listed for all patients.
Patients should be monitored periodically (per doctor-
patient consultation) for disease progression and closely
observed for asbestos-associated malignancies such as 
lung cancer, mesothelioma, and other cancers [American
Thoracic Society 2004; IARC 2012]. Colon cancer
screening should begin at age 50 and follow standard 
guidelines [Levin et al. 2008]
Pleural plaques are generally benign, but can
occasionally result in pulmonary impairment. As 
mentioned previously, when severe pleuritic pain
accompanies asbestos-related pleural disease, it requires
appropriate management [Harbut et al. 2009]. In 
addition, patients with asbestos-related pleural 
abnormalities may have or eventually get asbestosis or
asbestos-related cancers. Therefore, management of
asbestos-related pleural abnormalities involves
monitoring for asbestosis and all known related
malignancies and the general strategies listed for all 
patients.
Mesothelioma	 Diffuse malignant mesothelioma is almost always fatal.  
Median life expectancy following diagnosis ranges from 8
to 14 months in various studies [British Thoracic Society
2001].
For more information about the diagnosis and treatment
of mesothelioma, see
•	 British Thoracic Society Standards of Care
Committee, Statement on malignant mesothelioma
in the United Kingdom [British Thoracic Society
2001].
The National Cancer Institute's latest news on the
treatment of mesothelioma at
http://www.cancer.gov/cancertopics/types/malignantme 
sothelioma/.
Lung Cancer	 The treatment and management of asbestos-associated
lung cancer is the same as that of lung cancer from 
other causes.
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Key Points •	 The two primary strategies for managing non­
malignant asbestos-associated diseases.
o	 For all patients, occupational and
nonoccupational who have current asbestos 
exposure, remove the patient from further
exposure to asbestos.
o	 If a worker with exposure to asbestos, consult 
with or refer patient to an occupational specialist 
for advice regarding personal protective
equipment, work situation and medico-legal 
issues such as worker’s compensation and 
notifications.
o	 Monitor the patient carefully to facilitate early
diagnosis of treatable complications.
•	 The primary strategies for managing asbestosis are
to stop or limit exposure, stop smoking, prevent or 
aggressively treat chest infection, and assess the
level of impairment.
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Progress 
Checks
20.	 Primary strategies for managing asbestos-
associated diseases include
A. Smoking cessation.
B. Periodic pulmonary function tests.
C. Patient education.
D. All of the above.
To review relevant content, see “Introduction” in 
this section.
21. Managing asbestosis involves
A. Smoking cessation.
B. Providing pneumococcal and annual influenza
vaccines as recommended by Centers for
Disease Control and Prevention.
C. Respiratory therapies and pulmonary
 
rehabilitation.
 
D. All of the above.
To review relevant content, see “Asbestosis” in this
section.
What Instructions Should Be Given to Patients
Exposed to Asbestos?
Learning
Objectives
Upon completion of this section, you will be able to
•	 List four instructions for patient self-care and
•	 Describe two instructions for clinical follow-up.
Introduction	 Patients with a history of asbestos exposure will vary
widely in their clinical status. Some will be asymptomatic
and will continue to be so for life. Some will be
beginning to show signs of asbestos-associated disease,
and others will have more established disease. The care
you provide will depend on the clinical status of the
patient. All patients exposed to asbestos, however, need
some basic guidance on
•	 Self-care, so they can minimize further risks and
avoid complications to the extent possible and
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• Clinical follow-up, so they understand when and 
why to return for further medical attention.
ATSDR has developed a Patient Care and Education 
Instruction sheet on asbestos toxicity. It is designed to
provide patients with useful information and advice for
caring for themselves. It can be found at the end of this
case study.
Self Care	 Patients should be advised to avoid exposures and 
conditions that might further increase their risk of 
disease or worsen their existing condition.
Table 17. Self-care Advice to Asbestos-exposed 
Patients
Advice Rationale
If the patient smokes, 
advise them to stop
smoking and provide
advice on smoking 
cessation. All patients
should avoid exposure to
environmental tobacco
smoke.
Smoking decreases lung 
defenses, dramatically
increases risk of lung
cancer in case of asbestos 
exposure, and worsens
effects of asbestosis.
Avoid further exposure to
asbestos.
Further exposure to 
asbestos can worsen
asbestos related disease.
Avoid exposure to 
respiratory infections
especially influenza and 
pneumonia.
Chest infections can be
very serious in people
with asbestos-associated
respiratory conditions.
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Clinical 
Follow-up
Patients should be advised to consult their physicians if
they develop
• Any sign or symptom of chest infection and/or
• Signs or symptoms of other health changes such as 
weight loss, change in cough, coughing up blood 
(these especially since they could possibly be
related to an asbestos-associated disease).
ATSDR's Patient Care Instruction and Education sheet
has a more detailed checklist that you can use to
determine which types of follow-up are relevant for a
given patient.
Key Points • Counsel patients as follows:
o	 If a current smoker, stop smoking,
o	 Avoid environmental tobacco smoke and further
exposure to asbestos,
o	 Avoid exposure to respiratory infections, and
o	 Contact their physician if you have a chest
infection or other health changes.
•	 Use the Patient Education and Care Instruction 
sheet and prescribed follow up check list on 
asbestos toxicity
at http://www.atsdr.cdc.gov/csem/asbestos_2014/ 
docs/asbestos_patient_education.pdf .
Progress 
Check
22. Patients with significant past exposure to asbestos 
should
A. Stop smoking.
B. Avoid further exposure to asbestos.
C. Avoid exposure to respiratory infections and 
contact their doctor if they develop signs of
chest infection or other health changes.
D. All of the above.
To review relevant content see “Introduction” in
this section.
Sources of Additional Information
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Asbestos
Specific 
Information
Please refer to the following Web resources for more
information on the adverse effects of asbestos, the
treatment of asbestos-associated diseases, and
management of persons exposed to asbestos. 
•	 Agency for Toxic Substances and Disease Registry
(ATSDR) http://www.atsdr.cdc.gov
o	 For chemical, emergency situations
 CDC Emergency Response:  770-488-7100 
and request the ATSDR Duty Officer
PLEASE NOTE 
ATSDR cannot respond to questions about 
individual medical cases, provide second 
opinions, or make specific recommendations 
regarding therapy. Those issues should be 
addressed directly with your health care 
provider. 
o 	 For chemical, non-emergency situations 
 CDC-INFO http://www.cdc.gov/cdc-info/  
 800-CDC-INFO (800-232-4636) TTY 888-232­
6348 - 24 Hours/Day 
 E-mail: cdcinfo@cdc.gov 
o 	 Toxic Substances Portal – Asbestos 
http://www.atsdr.cdc.gov/substances/toxsubsta 
nce.asp?toxid=4  
o 	 Toxicological Profile for Asbestos 
http://www.atsdr.cdc.gov/toxprofiles/tp.asp?id= 
30&tid=4   
o 	 TOXFAQs for Asbestos 
http://www.atsdr.cdc.gov/toxfaqs/TF.asp?id=29 
&tid=4  
o 	 TOXFAQs for Asbestos (Spanish) 
http://www.atsdr.cdc.gov/es/toxfaqs/es_tfacts6 
1.html  
• Centers for Disease Control and Prevention (CDC)
http://www.cdc.gov/
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o 	 National Institute of Safety and Health (NIOSH) 

Safety and Health Topic - Chest Radiography:
  
http://www.cdc.gov/niosh/topics/chestradiography 
/   
o 	 ILO Classification System ­ 
http://www.ilo.org/safework/info/publications/WC 
MS_168260/lang--en/index.htm   
• 	 U.S. Environmental Protection Agency 
http://www.epa.gov   
• 	 Occupational Safety and Health Administration 
http://www.osha.gov 
General Please refer to the following Web resources for general 
Environmental information on environmental health. 
Health 
Information •	  Agency for Toxic Substances and Disease Registry 
http://www.atsdr.cdc.gov   
o Taking an Exposure History CSEM  
https://www.atsdr.cdc.gov/csem/csem.asp?cse 
m=33&po=0  
o	  To view the complete library of CSEMs 
http://www.atsdr.cdc.gov/csem/csem.html  
o Exposure History Worksheet  
http://www.atsdr.cdc.gov/csem/exphistory/docs 
/CSEMExposHist-26-29.pdf   
o 	 ATSDR Division of Regional Operations. 
 Through the working relationships they have 
established with EPA, other federal and state 
agencies, individual citizens, and community 
groups, regional representatives are able to 
maintain current and historic knowledge of 
the sites and issues in their regions. 
 ATSDR's Regional Offices, along with the 
states and territories that they cover as well 
as contact information, can be found at 
http://www.atsdr.cdc.gov/DRO/dro_contact.h 
tml  
o 	 ATSDR State Cooperative Agreement Program 
http://www.atsdr.cdc.gov/states/index.html  
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 The Cooperative Agreement Program provides 
essential support in communities nationwide 
to fulfill the mission of the Agency for Toxic 
Substances and Disease Registry (ATSDR).  
 The program funds 30 states and one tribal 
government to develop and strengthen their 
abilities to evaluate and respond to 
environmental public health issues. 
•	  Centers for Disease Control and Prevention (CDC) 
http://www.cdc.gov  
o 	 CDC works to protect public health and the 
safety of people, by providing information to 
enhance health decisions, and promotes health 
through partnerships with state health 
departments and other organizations.  
o 	 The CDC focuses national attention on 
developing and applying disease prevention and 
control (especially infectious diseases), 
environmental health, occupational safety and 
health, health promotion, prevention and 
education activities designed to improve the 
health of the people of the United States. 
•	  National Center for Environmental Health (NCEH) 
http://www.cdc.gov/nceh   
o 	 NCEH works to prevent illness, disability, and 
death from interactions between people and the 
environment. It is especially committed to 
safeguarding the health of populations that are 
particularly vulnerable to certain environmental 
hazards - children, the elderly, and people with 
disabilities. 
o 	 NCEH seeks to achieve its mission through 

science, service, and leadership.
  
•	  National Institute of Health (NIH) 
http://www.nih.gov  
o 	 A part of the U.S. Department of Health and 
Human Services, NIH is the primary Federal 
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agency for conducting and supporting medical
research.
•	 National Institute of Occupational Safety and
Health (NIOSH) http://www.cdc.gov/niosh/
o	 NIOSH is in the U.S. Department of Health and
Human Services and is an agency established 
to help assure safe and healthful working 
conditions for working men and women by
providing research, information, education, and 
training in the field of occupational safety and
health.
•	 American College of Occupational and 
Environmental Medicine (ACOEM) 
http://www.acoem.org/
o	 ACOEM is the nation's largest medical society
dedicated to promoting the health of workers
through preventive medicine, clinical care,
research, and education.
o	 Its members are a dynamic group of physicians
encompassing specialists in a variety of
medical practices united via the College to
develop positions and policies on vital issues
relevant to the practice of preventive medicine
both within and outside of the workplace.
•	 American College of Medical Toxicologists (ACMT) 
http://www.acmt.net
o	 ACMT is a professional, nonprofit association of
physicians with recognized expertise in medical 
toxicology. 
o	 The College is dedicated to advancing the
science and practice of medical toxicology
through a variety of activities.
•	 American College of Preventive Medicine (ACPM)
http://www.acpm.org
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  o	 ACPM is the national professional society for
physicians committed to disease prevention 
and health promotion.  
o 	 ACPM's 2,000 members are engaged in 
preventive medicine practice, teaching and 
research.  
• 	 Association of Occupational and Environmental 
Clinics (AOEC) http://aoec.org  
o 	 AOEC is a network of more than 60 clinics and 
more than 250 individuals committed to 
improving the practice of occupational and 
environmental medicine through information 
sharing and collaborative research. 
• 	 Pediatric Environmental Health Specialty Units 
(PEHSUs)  http://www.pehsu.net 
o 	 PEHSU form a respected network of experts in 
children's environmental health.  
o 	 The PEHSU were created to ensure that 
children and communities have access to, 
usually at no cost, special medical knowledge 
and resources for children faced with a health 
risk due to a natural or human-made 
environmental hazard. 
o	  Located throughout the United States, Canada, 
and Mexico, PEHSU professionals provide 
quality medical consultation for health 
professionals, parents, caregivers, and 
patients. The PEHSUs are also dedicated to 
increasing environmental medicine knowledge 
among healthcare professionals around 
children’s environmental health by providing 
consultation and training. 
• 	 American Association of Poison Control Center 
(AAPC) http://www.aapcc.org  
o 	 The American Association of Poison Control 
Centers can be contacted for questions about 
poisons and poisonings. The web site provides 
information about poison centers and poison 
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prevention. AAPC does not provide information 
about treatment or diagnosis of poisoning or 
research information for student papers. 
o	  American Association of Poison Control Centers 
may be contacted at 1-800-222-1222. 
• 	 The U.S. National Library of Medicine’s Toxicology 
and Environmental Health Information Program 
(TEHIP) http://sis.nlm.nih.gov/enviro.html  
o 	 TEHIP maintains a comprehensive toxicology 
and environmental health web site that 
includes access to resources produced by TEHIP 
and by other government agencies and 
organizations.  
o 	 This web site includes links to databases, 
bibliographies, tutorials, and other scientific 
and consumer-oriented resources.  
o 	 TEHIP also is responsible for the Toxicology 
Data Network (TOXNET®), an integrated 
system of toxicology and environmental health 
databases that are available free of charge on 
the web http://toxnet.nlm.nih.gov  
Suggested
Reading
For further information on asbestos-associated diseases,
please refer to
American Thoracic Society. 2004. Diagnosis and initial 
management of nonmalignant diseases related to
asbestos. American Journal of Respiratory and Critical 
Care Medicine 170:691-715.
British Thoracic Society Standards of Care Committee. 
2001. Statement on malignant mesothelioma in the
United Kingdom. Thorax 56:250-265.
Peipins L, Lewin M, Campolucci S, Lybarger JA, Miller A, 
Middleton D, et al. 2003. Radiographic abnormalities
and exposure to asbestos-contaminated vermiculite in
the community of Libby, Montana. Environmental Health
Perspectives 111(14):1733-1739.
Posttest 
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Posttest 1. What is asbestos?
A. A group of naturally occurring fibrous silicate
minerals.
B. A fibrous substance used widely throughout the
United States in the construction, shipbuilding, 
and automotive industries until the 1970s.
C. A heat-stable substance commonly used in 
insulation, pipe coverings, boilers, brake pads,
and many other products.
D. All of the above.
2. Which asbestos exposure pathway most commonly
leads to illness?
A. Ingestion.
B. Inhalation.
C. Dermal contact.
D. All are equally important.
3. Of the following, in the United States, the people in
the general population most at risk of exposure to 
asbestos today are
A. People who work in asbestos mining and milling.
B. Household contacts of workers engaged in the
manufacture of asbestos-containing products.
C. People working or living in homes and buildings
with loose, crumbling, or disturbed asbestos
materials.
D. People who garden with vermiculite potting soil.
4. OSHA requires workers who are exposed to 
asbestos at levels higher than the PEL of 0.1
fibers/cc of air (8-hour TWA) to
A. Receive medical surveillance.
B. Be hospitalized immediately.
C. File claims for work-related injuries.
D. All of the above.
5. After inhalation, asbestos fibers
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A. Are retained in the lungs, especially the lower
lung fields.
B. Initiate responses that can lead to fibrosis of
lung tissue.
C. Initiate responses that can lead to
 
carcinogenesis.
 
D. All of the above.
6.	 Of the respiratory conditions associated with
asbestos exposure, the condition that is not
malignant but is associated with significant 
restrictive deficits is
A. Asbestosis.
B. Asbestos-related pleural abnormalities.
C. Lung carcinoma.
D. Pleural mesothelioma.
7.	 Which condition is most likely to occur secondary to 
asbestos-associated pulmonary fibrosis?
A. Peritoneal mesothelioma.
B. Colon cancer.
C. Cor pulmonale.
D. Constrictive pericarditis.
8.	 The most important risk factor for asbestos-
associated diseases are
A. Genetic polymorphisms and exposure to air
pollution.
B. Total exposure to asbestos and smoking.
C. Frequency of respiratory infections and
 
coexistence of other fibrotic respiratory
 
conditions.
 
D. All are equally important.
9.	 A 64-year-old male who worked in shipyards in the
United States in the 1960s and 1970s presents to
his physician complaining of breathlessness,
especially when he works or exercises. He says this 
symptom began several years ago but was so minor
that he was not concerned. He also complains of a 
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slight, nagging dry cough. Of the asbestos-
associated diseases, the most likely culprit is
A. Asbestosis.
B. Asbestos-related pleural abnormalities.
C. Lung carcinoma.
D. Pleural mesothelioma.
10.	 On auscultation of a patient with asbestosis, you
are most likely to hear
A. Normal breath sounds.
B. Absent breath sounds.
C. Bibasilar end inspiratory rales.
D. Rhonchi.
11. As part of taking the exposure history, you should
explore
A. Possible occupational exposures to asbestos.
B. Possible paraoccupational and secondary
exposures to asbestos.
C. Use of personal protective equipment.
D. All of the above.
12. Pulmonary function tests of a patient with 
asbestosis are most likely to show
A. Normal results.
B. Low FVC.
C. Low FEV1.
D. Low FEV1/FVC.
13. On chest radiograph, small, irregular opacities in
the bases of both lung fields is suggestive of
A. Asbestosis.
B. Pleural plaques.
C. Benign asbestos pleural effusion.
D. Diffuse pleural thickening.
14. In caring for a patient who was exposed to
asbestos, it is important to
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A. Take steps to avoid further exposure to 
asbestos.
B. Counsel the patient to stop smoking.
C. Monitor the patient to facilitate early treatment 
of chest infections.
D. All of the above.
15. Patients diagnosed with an asbestos-associated
disease should be instructed to
A. Continue working with asbestos as long as they
use PPE.
B. Contact their doctor if they develop any sign of
respiratory infection or other health change.
C. Receive influenza and pneumococcal vaccines
only if they meet other criteria for being high 
risk.
D. All of the above.
16. Asbestos fibers are released into the air mainly
when
A. Asbestos-containing materials are loose, 
crumbling, or disturbed.
B. Asbestos is fixed in solid materials such as
wallboard.
C. Asbestos-bearing rock lays unexposed deep 
underground.
D. All of the above.
17.	 Which of the following is EPA's MCL for asbestos in
drinking water?
A. 0.07 fibers per liter of drinking water.
B. 7 million fibers per liter of drinking water.
C. 700 fibers per liter of drinking water.
D. 70,000 fibers per liter of drinking water.
18. Diffuse interstitial fibrosis resulting from inhalation 
of asbestos fibers and producing restrictive lung 
disease and progressive exertional dyspnea is 
termed
A. Lung carcinoma.
111
 
 
 
  
  
   
    
  
  
  
 
  
   
  
  
 
   
   
 
   
   
  
 
  
  
  
  
  
  
   
 
  
 
   
   
  
B. Pleural mesothelioma.
C. Asbestosis.
D. Asbestos-related pleural abnormalities.
19.	 Asbestos-related pleural abnormalities include
which of the following?
A. Pleural plaques.
B. Benign pleural effusions and diffuse pleural
thickening.
C. Rounded atelectasis.
D. All of the above.
20. The most typical abnormal finding on physical
examination of a patient with significant asbestosis
is
A. A “doughy” feeling in the abdomen.
B. Bibasilar inspiratory rales on pulmonary
auscultation.
C. Clubbing of the fingers.
D. All of the above.
21. The two most important tests for diagnosing
asbestos-associated diseases are
A. BAL and lung biopsy.
B. CT and HRCT scans.
C. Chest radiograph and pulmonary function tests.
D. Blood studies and colon cancer screening.
22. Managing asbestosis involves
A. Smoking cessation.
B. Annual influenza and pneumococcal vaccines as 
recommended by the Centers for Disease 
Control.
C. Respiratory therapies and pulmonary
 
rehabilitation.
 
D. All of the above.
23. Patients who were exposed to asbestos should
A. Stop smoking.
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B.	 Avoid further exposure to asbestos.
C. Avoid exposure to respiratory infections and 
contact their doctor if they get signs of infection
or other health changes.
D. All of the above.
Relevant To review content relevant to the posttest questions, 
Content see:
Question Location of Relevant Content 
1 What Is Asbestos? 
• Explain what asbestos is 
2 How Are People Exposed to Asbestos 
• 	 Identify the most important route 
of exposure to asbestos which leads 
to health effects. 
3 Who Is at Risk of Exposure to Asbestos  
• 	 Name the populations most heavily 
exposed to asbestos 
•	  Describe who is at risk of domestic 
exposure to asbestos 
4 What Are U.S. Standards for Asbestos 
Levels 
•	  Explain the OSHA PEL for asbestos 
5 What Is the Biological Fate of Asbestos 
• 	 Identify where asbestos fibers are 
most likely to be found in the body 
How Does Asbestos Induce Pathogenic 
Change 
•	 Describe the mechanisms by which 
scientists hypothesize asbestos 
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induces pathogenic changes in the 
lungs 
6 What Respiratory Diseases Are 
Associated with Asbestos 
•	  Describe the four respiratory 
conditions associated with asbestos 
exposure 
7 What Other Diseases Are Associated with 
Asbestos 
•	  Identify non-respiratory conditions 
that might be associated with 
exposure to asbestos 
8 How Should Patients Exposed to Asbestos 
Be Evaluated 
• 	 Identify the primary focuses of the 
patient exposure history  
 
9 How Should Patients Exposed to Asbestos 
Be Evaluated 
• 	 Identify the primary focuses of the 
patient exposure history 
 
10 How Should Patients Exposed to Asbestos 
Be Evaluated 
• 	 Describe the most typical finding on 
the patient evaluation 
 
11 How Should Patients Exposed to Asbestos 
Be Evaluated 
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• 	 Identify the primary focuses of the 
patient exposure history (exposure 
and medical) history and 
12 What Tests Can Assist with Diagnosis of 
Asbestos-related Disease? 
• 	 Describe pulmonary function tests 
associated with asbestosis 
13 What Tests Can Assist with Diagnosis of 
Asbestos-related Disease? 
•	  Describe chest radiograph findings 
associated with other asbestos-
associated diseases 
14 How Should Patients Exposed to Asbestos 
Be Treated and Managed 
• 	 Identify two primary strategies for 
managing asbestos associated 
diseases 
15 What Instructions Should Be Given to 
Patients  
•	  List two instructions for clinical 
follow-up 
16 Where is asbestos found 
• 	 Describe how asbestos is released 
into the air 
17 What Are U.S. Standards for Asbestos 
Levels 
• 	 Explain the EPA maximum 
contaminant level for asbestos in 
drinking water 
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18 What Respiratory Diseases Are
Associated with Asbestos
•	 Describe the four respiratory
conditions associated with asbestos 
exposure
19 What Respiratory Diseases Are
Associated with Asbestos
•	 Describe the four respiratory
conditions associated with asbestos 
exposure
20 How Should Patients Exposed to Asbestos
Be Evaluated
•	 Describe the four respiratory
conditions associated with asbestos 
exposure
21 What Tests Can Assist with Diagnosis of
Asbestos-related Disease?
•	 Describe chest radiograph findings
associated with other asbestos-
associated diseases
22 How Should Patients Exposed to Asbestos
Be Treated and Managed
•	 Describe specific strategies for
managing asbestosis.
23 What Instructions Should Be Given to
Patients
•	 List four instructions for patient
self-care
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